2005-07-14 14:48:00 |
Disclosure Document |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b464875df45ee2ec6ebead332bede4ce |
|
2005-08-11 12:38:00 |
Admission to Official List |
1 |
https://app.sharelinktechnologies.com/announcement/asx/886e17a2119b870f8e330929d4b69c5d |
Admission to Official List
|
2005-08-11 19:20:00 |
NeuroDiscovery closes IPO and Completes Acquisition |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a13a672ac60371e673b3098a95f1fde |
|
2005-08-12 11:11:00 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6d84f17d8b3771447248e53b8619df0 |
|
2005-08-12 11:11:00 |
Pre-Quotation Disclosure |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfc4ae233a8065a7bf7da5c8d34d4350 |
Stock Exchange Announcement - Other
|
2005-08-12 11:11:00 |
Appendix 1A - ASX Listing application & agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e31cab89716980e7e4c7714c5e5c51a9 |
Company Administration - Other
|
2005-08-12 11:12:00 |
Top 20 shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e73ec1de4c49da79b78b58b422efdb7 |
|
2005-08-12 11:12:00 |
Spread of Holdings |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d31b010a36aed0b877bbd535b979a0cd |
Security holder details - Other
|
2005-08-12 11:13:00 |
Incentive Option Scheme |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebadd485e41baf97d2369f329571542c |
Company Administration - Other
|
2005-08-12 11:13:00 |
Confirmation of completion of share sale agreements |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba7e346ff77ea1640fbd4d4903c0d91f |
|
2005-08-12 11:14:00 |
Corporate Governance |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d23c8250d5b6e0fe6567ce5a2814d2a |
Company Administration - Other
|
2005-08-12 11:14:00 |
List of Escrowed Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f8f6616fcb2d78c008f2a4c4dd1567c |
|
2005-08-15 11:49:00 |
Becoming a substantial holder x7 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1374e4032703e19e3a28e572a3734619 |
Becoming a substantial holder
|
2005-08-15 15:23:00 |
Initial Director's Interest Notice x5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3cf050b2a32844970ed0f029b09f32b6 |
Initial Director's Interest Notice
|
2005-08-16 11:41:00 |
To attend & present with GSK at World Pain Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d9ee2ec5e11043fd74370b2b2e897f0 |
|
2005-08-18 12:06:00 |
NeuroSolutions to Collaborate with Epichem |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38b4a1aff4886bff6d04f3b8ebffbdcb |
|
2005-08-22 11:55:00 |
Change of Director's Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/513e9af705128453907e02932305849c |
Change of Director's Interest Notice
|
2005-08-25 12:22:00 |
Neurosolutions appoints Manufacturer for lead drug candidate |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90219f29f4c55e850b1d94c57fe449b8 |
Company Administration - Other
|
2005-08-29 12:42:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/66c31dfc6248361a1174cf962f4b0be1 |
Change of Director's Interest Notice
|
2005-08-30 12:14:00 |
Neurosolutions & Sosei file patent for lead pain compound |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5d3816ff10e7d0cd0258e0a3473eb94a |
|
2005-08-31 09:33:00 |
Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0d73a8df65c49bbb6f0aff562cea817 |
Full Year Directors' Report
|
2005-09-02 11:36:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98827f4ad8758f14d1ad04cf1f4e225b |
Change of Director's Interest Notice
|
2005-09-06 11:38:00 |
NeuroSolutions & GlaxoSmithKline enter Revenue Contract |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f59fcf954df8f9f59b7d634a7b829e96 |
|
2005-09-07 11:08:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c125e7f57cc635dd5beacc97d4d79d68 |
Change of Director's Interest Notice
|
2005-09-07 13:48:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a6c6b17757a67d1bde13e76041723ee |
Change of Director's Interest Notice
|
2005-09-09 10:29:00 |
NeuroSolutions & Epichem to Co-Market Activites |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f27e10fef745bdf9ab325f69e0245114 |
|
2005-09-20 13:15:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4168825ba453628a1787339f7acaf7c |
Change of Director's Interest Notice
|
2005-09-27 11:17:00 |
Neurosolutions & Senexis enter into revenue contract |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97dd629cbd1f87f39b2d075e17df3fae |
|
2005-09-30 17:16:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73c6b93b242814bb29435f9b9a39cfa7 |
|
2005-10-06 12:32:00 |
Neurosolutions enters into a revenue contract with Alzhyme |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cc2687d329b6b8bc4ce5b961cadda396 |
|
2005-10-07 13:44:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2991b0ff87cd4755334b9c6d9c624f64 |
Notice of Annual General Meeting
|
2005-10-21 09:49:00 |
NeuroSolutions enters into another revenue contract with GSK |
1 |
https://app.sharelinktechnologies.com/announcement/asx/21e772376b81cdb8572b9b367ece79e8 |
|
2005-10-21 12:29:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ce10d7d43f8e79c715b5a5943a1ab218 |
Commitments Test Entity - First Quarter Report
|
2005-10-21 12:30:00 |
Quarterly Highlights |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7266b3aad89665c306f82b828967c332 |
|
2005-11-10 13:49:00 |
NeuroSolutions to Exhibit at NeuroScience 2005 Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e7430798e399f190954be9de1a1097e |
|
2005-11-18 11:09:00 |
NeuroSolutions enters into revenue contracts with GSK |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad970032ba6a653248ce76868921c85b |
|
2005-11-18 14:43:00 |
AGM 2005 Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42678a2a11aae71712913922f02c8a04 |
Chairman's Address to Shareholders
|
2005-11-18 14:47:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebb3c04f40635d1254d5bd304fe8660c |
|
2005-11-18 14:52:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/067409154ee8d16b7ab32d8047948e96 |
Change of Director's Interest Notice
|
2005-11-18 14:53:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93357395b61ba9eaa4dabf9169f95032 |
Change of Director's Interest Notice
|
2005-11-18 15:02:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de79339164cc69e436daf3acd5eb08a5 |
|
2005-12-06 12:11:00 |
Enters into Revenue Contract with Major US Pharmaceutical Co |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a58f85ca6bdbef23369856d8fe979fa |
|
2005-12-08 14:53:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06f3c3ad53b9b10d7f8dba4b29c56274 |
Change of Director's Interest Notice
|
2005-12-13 13:04:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d52abe53901cef36ec64ca9ce784cd35 |
Change of Director's Interest Notice
|
2005-12-13 13:41:00 |
Amended Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ad2e93e5ae700d1502449eecec99360 |
Change of Director's Interest Notice
|
2005-12-16 14:24:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bfa0028890f1fcf0169f024be0b0b35f |
Change of Director's Interest Notice
|
2005-12-19 12:51:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/661a6450e45fa0df3cba2b51d493c4e0 |
Change of Director's Interest Notice
|
2006-01-19 12:00:00 |
NeuroDiscovery & CSIRO to Collaborate |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2ad624381c3115bfbc1d2d8af0681640 |
|
2006-01-27 11:56:00 |
Neurosolutions & Pharmidex Enter Co-Marketing Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/255c711b1aef59a5af5a5e3f91989534 |
|
2006-01-30 09:33:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c474dea268f867cfa947a117262c0261 |
Commitments Test Entity - Second Quarter Report
|
2006-01-30 09:35:00 |
Quarterly Highlights - 31 December 2005 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b2c4e2875998c4b878afb51ddb4ef9c |
|
2006-02-02 13:36:00 |
Change of Director's Interest Notice x3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2eba5dc9061b03b9670e5425f741b2fd |
Change of Director's Interest Notice
|
2006-02-15 12:15:00 |
Change of Director's Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e6ecbfdebf95b0cc05fdb547dc4f409 |
Change of Director's Interest Notice
|
2006-02-27 13:50:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e56f3de4fc83ce9ae96106141bb00adc |
Change of Director's Interest Notice
|
2006-03-03 13:11:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00fa73062d4a7cd9898b86cae7d7827c |
Half Year Directors' Statement
Half Year Directors' Report
|
2006-03-07 09:33:00 |
NeuroSolutions expands into Cambridge (UK) |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6c18ae2de7f2c11805044d123a5c13bc |
|
2006-03-14 09:50:00 |
NeuroSolutions extends collaboration agreement with Ampika |
0 |
https://app.sharelinktechnologies.com/announcement/asx/857d7cf39d3f69a34710f25c353e1015 |
|
2006-03-22 08:29:00 |
Neurosolutions & Senexis enter into add revenue contract |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1168125e905263a3657541e9543c63ba |
|
2006-04-03 10:18:00 |
NeuroSolutions enter Collaboration Agreement with Cameleon |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cfe8628b8b33e10f5bdf69d3a91b0482 |
|
2006-04-11 10:07:00 |
NeuroDiscovery & Insymbiosis enter into Marketing Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5450718ba1094009a0362cef6470ee2c |
|
2006-04-11 12:19:00 |
Release of Restricted Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be5f777c1bdc74261e2bc4df4d9d90d8 |
|
2006-04-21 08:30:00 |
Quarterly Highlights - 31 March 2006 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd01c3d4e1a60ce2467bd150bd754646 |
Commitments Test Entity - Third Quarter Report
|
2006-04-21 08:30:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13868771b7e7f993aa18b97c9f73ffed |
Commitments Test Entity - Third Quarter Report
|
2006-04-26 15:54:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc55941aced66ce24de9aa0f9b81f3ee |
|
2006-05-03 09:19:00 |
NeuroSolutions completes Scale-up of 3 Development Candidate |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c6d4e4058c3bbb573038642eb1863f28 |
|
2006-05-05 11:51:00 |
Enters into Collaboration Agreement with Gentronix |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d977167f3b6f46abfb7752242be1c846 |
|
2006-05-09 09:25:00 |
Finalises Collaboration Agreement and Development Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4976b97d2d4773e548264a18dc51b635 |
|
2006-05-11 13:51:00 |
Market Update - Roadshow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b96b9e827aa433d86df4acd102a4203c |
|
2006-05-12 09:00:00 |
NeuroSolutions to co-host international conference on pain |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0a810c4913e8f56e0781a3797ace252 |
|
2006-05-15 11:31:00 |
Change of Director's Interest Notice x2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ad72a3a809c32db70cbf9f470bab3c5 |
Change of Director's Interest Notice
|
2006-05-24 12:15:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d1755e0441cf9b06e0a05c84d339317 |
Change of Director's Interest Notice
|
2006-05-25 15:30:00 |
Market Update Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b05b913048871bdc3fc00a6f60b5bbc |
|
2006-06-13 13:37:00 |
WH Ireland Research Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a9a26819620c16c997bb8c171c1517a |
|
2006-06-20 11:15:00 |
Neurosolutions enters into $200000 Revenue Contract |
1 |
https://app.sharelinktechnologies.com/announcement/asx/76b5193f39ae5b57fc396e2abba79a21 |
|
2006-06-23 12:57:00 |
Change of Director's Interest Notice x4 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d10bdd5dab75ae2189947462c85248a |
Change of Director's Interest Notice
|
2006-06-26 12:55:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4eb3e3d9c5f3c6f0db3cbb9e554ee0c |
Becoming a substantial holder
|
2006-06-30 14:14:00 |
Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b440fbcdb16dcc6e2d470612cf52febd |
Director Appointment/Resignation
|
2006-06-30 14:15:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5fd9d74215bfe2d5104c75bd50bf3d78 |
Final Director's Interest Notice
|
2006-07-04 12:13:00 |
Achieves Revenue Milestone Ahead of Schedule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/518d7b28b162c1253d4f53b6f95da577 |
|
2006-07-04 12:15:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e31fd846ed399b70f56c5f8de97a07b |
|
2006-07-05 15:02:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef99d4af4073868d2d0676ebb19d7e4f |
Change of Director's Interest Notice
|
2006-07-10 18:16:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cdacb05c7e3906f131bc2ba3a8c9c72b |
|
2006-07-17 08:30:00 |
Stem Cell Sciences & Neurosolutions ann collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1a7cb7b32447249a49d75d345430f14c |
|
2006-07-21 11:23:00 |
Neurosolutions to trial & market device with Scientifica |
1 |
https://app.sharelinktechnologies.com/announcement/asx/58b4588fbc4d89c0c51bea7636acaef5 |
|
2006-07-26 15:20:00 |
Release of restricted securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6994411e26af00588cbd7338a8b30762 |
|
2006-07-28 10:34:00 |
Quarterly Highlights |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bfc3644a1fe23164f4d7226fe1cb1a66 |
|
2006-07-28 10:34:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/646d9b8f2153c7d1050de1e0f51e3900 |
Commitments Test Entity - Fourth Quarter Report
|
2006-08-02 16:07:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2160f983d3e531b813606aa730e2e076 |
Change of Director's Interest Notice
|
2006-08-10 12:39:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/536e24c8b106a247a610e2513dc05c41 |
|
2006-08-17 12:49:00 |
NeuroSolutions initiates pre-clinical testing on NSL-043 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ce9132373fe9402f60dc93ce38cba092 |
|
2006-08-21 08:30:00 |
NeuroSolutions expands into King's College London |
1 |
https://app.sharelinktechnologies.com/announcement/asx/be51de40af7acd61c256d8c4d983d6e9 |
|
2006-08-30 12:03:00 |
NeuroSolutions Enters Into Revenue Generating Contract |
1 |
https://app.sharelinktechnologies.com/announcement/asx/419617b4266c35435242c54ce6ab070a |
|
2006-08-31 11:57:00 |
Enters additional revenue generatingcontracts with USCompany |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e5b3255fb218ac99dbc1a12c94c2f91 |
|
2006-09-05 08:29:00 |
NeuroSolutions to attend NeuroScience conference in USA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f1e9998d7b1ad18eba18b88460f53a5 |
|
2006-09-06 11:07:00 |
Preliminary Final Report/Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c35652e014e4fea4f692602fa0da08f9 |
Full Year Directors' Statement
Full Year Directors' Report
|
2006-09-11 14:04:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d222c3dca85e7f961de986a2c76e460c |
Change of Director's Interest Notice
|
2006-09-21 10:53:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4453aaa2ddf808ed55d9b702a4e7ca1 |
Change of Director's Interest Notice
|
2006-09-25 11:29:00 |
Enters Revenue Contract with US Biopharma |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11355037c360d1b60b04da36162b1e61 |
|
2006-10-04 14:30:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e33895122c8faa0631e16ce07407bc3a |
Notice of Annual General Meeting
|
2006-10-17 12:44:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92992ea0b36f549e85f7fc9536d4ef09 |
Change of Director's Interest Notice
|
2006-10-31 10:28:00 |
Quarterly Highlights 30 September 2006 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d830b92fe6e2df67708470876a538e76 |
|
2006-10-31 10:35:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e238a95a7c0b332475b0c3d1ee385c4f |
Commitments Test Entity - First Quarter Report
|
2006-11-08 13:37:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/050264959eb420bb737bdda649407fa6 |
Change of Director's Interest Notice
|
2006-11-10 10:39:00 |
NeuroSolutions Increases Ownership Int. in NSL-101 to 100% |
1 |
https://app.sharelinktechnologies.com/announcement/asx/67e68800a55bdf6e5632c45449a7271d |
Asset Acquisition & Disposal - Other
|
2006-11-10 14:38:00 |
2006 AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1986fcae2c358d1b6fb6091fc61e63cf |
|
2006-11-10 14:52:00 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19d594785c6039d2c6b87b76dc818d87 |
|
2006-11-10 15:02:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/577d00178e2d23cd00d1e11f410ee7fa |
|
2006-11-10 15:08:00 |
Change of Director's Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27e269c526deabd754c587f9841b6655 |
Change of Director's Interest Notice
|
2006-11-14 13:56:00 |
Change of Director's Interest Notice x2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40dfaa77ddc68ff80b84d72e9137547b |
Change of Director's Interest Notice
|
2006-11-23 12:56:00 |
Signs Revenue Generating Contracts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/936414d9e87c14e17172988ef1e7eb54 |
|
2006-11-27 12:19:00 |
NeuroSolutions signs first significant contract on device |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89c237c4511d5702f6591cf263d960ad |
|
2006-11-29 08:30:00 |
Neurosolutions signs revenue generating contract |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b22defa5f3bee93a22fe6f0450445bbc |
|
2006-12-11 08:29:00 |
NeuroSolutions Pain Conference Commences |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b05b80d8666d32f3f382edb98a8a7410 |
|
2006-12-19 13:49:00 |
Change of Director's Interest Notice x3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1dea47332a104aa297bc221c2f3a287e |
Change of Director's Interest Notice
|
2007-01-11 14:17:00 |
Concludes Licence Agreement for NSL-101 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/19dbff6540646517907cbd0433db9b32 |
|
2007-01-23 12:12:00 |
Response to ASX Query re Share Price |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fbadb25faa081506556ca5e8be395e6d |
|
2007-01-29 11:11:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a79d72a14c512a8a485ed412e9365415 |
Commitments Test Entity - Second Quarter Report
|
2007-01-29 11:12:00 |
Quarterly Highlights - 31 December 2006 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c927af5dc638f2538d0d8c725a333019 |
|
2007-01-31 10:14:00 |
NeuroSolutions Master Services Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/da3b4a84b6a87c64cfc9a7919056b40b |
|
2007-02-05 11:48:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73f8fbf7dbee340a2596cd4ba452b106 |
Change of Director's Interest Notice
|
2007-02-21 17:38:00 |
Sosei announces progress of SD118 towards Phase 1 Studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d217cc8086af994aeecc3fc317caaec0 |
|
2007-02-23 16:05:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/49bfb638f52ff8df9ced7b7ac4c30d53 |
|
2007-03-01 09:34:00 |
Change of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/74b92e6caf2ca35eb160ed0cc2569c38 |
Company Secretary Appointment/Resignation
|
2007-03-19 08:31:00 |
Approval for Phase I Clinical Trial NSL-043 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d83eaa8ef98dd0f59059c041d46f6bb9 |
|
2007-03-20 08:27:00 |
Presentation - Excellence in Biotech & Investment Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d7848479153981573a3072dfe75ded3 |
|
2007-03-26 12:19:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d99d5c6ff8b6860f8a7100ab785c15b9 |
Change of Director's Interest Notice
|
2007-03-26 12:39:00 |
CAP Cancellation: Not NDL announcement should be for CRL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e029246a975736ca5d11c22a6815217 |
|
2007-04-12 12:35:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32f6b328874ef777b616a0431e972557 |
Change of Director's Interest Notice
|
2007-04-27 10:38:00 |
Neurosolutions Signs Contract with Major Pharma |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4f1523d94a2e3745b824e24f00768dec |
|
2007-04-30 13:57:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/caae5b6c008af841e4dbed257f88ec55 |
Commitments Test Entity - Third Quarter Report
|
2007-04-30 13:58:00 |
Research & Development programmes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/463b183b1ed8959e6bb4b922a0851f1c |
|
2007-05-02 08:29:00 |
Neurodiscovery & CSIRO expand collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0e7f2022f428201153f1340f168bf08f |
|
2007-05-07 11:00:00 |
Neurosolutions Signs Significant Services Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4bd45950770533ca30908d84cc8b01f0 |
|
2007-05-28 09:28:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d107b81b8c1a860d8be4d3db7237ef5f |
|
2007-05-30 09:48:00 |
$3.25 million Capital Raise |
1 |
https://app.sharelinktechnologies.com/announcement/asx/322367bf7fd1da9f1e4f75a836021931 |
Company Administration - Other
|
2007-05-30 09:48:00 |
Sosei Announces Start of SD118 Phase 1 Studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/87da35e972de65b067b6c68c1756a30e |
|
2007-05-30 09:51:00 |
To Invest $1.5million in Neurodiscovery |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e230a385aac3995879f91e26e076caf2 |
|
2007-05-30 19:20:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ab923ac646fde765776f28d7db79e6ce |
|
2007-06-06 18:47:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6414e087ff377158e437f0fc62f877e2 |
Ceasing to be a substantial holder
|
2007-06-08 17:14:00 |
Becoming a substantial holder from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33b322b0fbda78aa8afa43d8887e984f |
Becoming a substantial holder
|
2007-06-12 08:26:00 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5078e6209178f8ae57661fdb037ba9a |
Notice of General Meeting
|
2007-06-20 08:29:00 |
Shareholder Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4025fcf4efdfcf2fdfea49bef24eabbb |
|
2007-07-04 11:51:00 |
Signs First Safety Pharmacology Contract |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7eb6fd8dc835ac077b5d6b4dea75fa9f |
|
2007-07-06 08:30:00 |
SPP Continued Until 20 July 2007 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b1d8f0dd4ad51be2974a7b9855a457c3 |
|
2007-07-11 14:07:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf4e4db51f50de699cdd028ff5f5351b |
|
2007-07-11 14:12:00 |
A$2.75m Placement Completed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9db15160411e4599c36dae895d457394 |
|
2007-07-11 14:14:00 |
SECOND TRANCHE INVESTMENT BY BIOTECH CAPITAL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bfc413f37392bc6ccd7f0e0186bb4ab |
|
2007-07-11 14:17:00 |
BTC SecondTranche Investment in Neurodiscovery Limited |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31c1c42e752544654b30c258bb039e61 |
|
2007-07-12 10:59:00 |
Phase II Approval for NSL 101 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1d7362b9cea732eecb488d3300349993 |
|
2007-07-24 13:46:00 |
Share Purchase Plan Completion |
0 |
https://app.sharelinktechnologies.com/announcement/asx/369ad9b81170b42484adeae19cbf77cf |
|
2007-07-26 16:01:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc6dc009c77fd63ab326cb1b9eab3563 |
|
2007-07-26 16:02:00 |
Section 708A Notice for Placement Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/322a94a5bab1add2a3859de320be2ca7 |
|
2007-07-31 10:46:00 |
Quarterly Highlights - 30 June 2007 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7c7afb40a160a3fdab0bf6d43fa8fdb |
|
2007-07-31 11:02:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6c96ac259ebac82217ccd0dafe7d34a |
Commitments Test Entity - Fourth Quarter Report
|
2007-08-01 13:12:00 |
Release of Restricted Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f2e8b9553d808e99cfb13091913ce523 |
|
2007-08-01 17:09:00 |
Change of Directors Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7e50e9b671379cec77f154325010d6a |
Change of Director's Interest Notice
|
2007-08-14 15:58:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2871d7fdf134c7a57a346a5e15b4063b |
|
2007-08-30 18:52:00 |
Director Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/061b21c9c2c43519e2c786831e220f49 |
Director Appointment/Resignation
|
2007-08-30 18:52:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/05b1c0b841498fce3b58296c17e375b2 |
Final Director's Interest Notice
|
2007-08-31 15:31:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/77c0a99775bb488253bac511e5ee5902 |
Initial Director's Interest Notice
|
2007-08-31 18:51:00 |
Full Year Statutory Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6605270e6b693f2620fff7590a4b2b2e |
Full Year Directors' Statement
Full Year Directors' Report
|
2007-09-03 08:38:00 |
NSL-043 Phase I Study Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c742d818a1667e3ef4c675ac9164ddcb |
|
2007-09-17 08:27:00 |
Research Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfebf5c31dada7cd45f26df9eb6d0300 |
|
2007-09-17 18:10:00 |
Company Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96570728d9b4646dfcc402fe38a52409 |
|
2007-09-28 09:53:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de22a2626c7646d07a645a389f09afcf |
Full Year Directors' Statement
Full Year Directors' Report
|
2007-10-01 08:47:00 |
Change of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8fa7467b0d92fd68a486e6c11b629508 |
Company Secretary Appointment/Resignation
|
2007-10-08 16:07:00 |
London Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b301e1b9f8555f2455cef5476495bf8f |
|
2007-10-18 13:27:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ff47b23875705e71bae748549d11540 |
Notice of Annual General Meeting
|
2007-10-18 13:28:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48e2b2e8ea3807341ab67234cce2f39f |
Security holder details - Other
Full Year Directors' Statement
Full Year Directors' Report
|
2007-10-18 14:25:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82e05cb98f52008de01cc3b0230ca323 |
Change of Director's Interest Notice
|
2007-10-25 12:41:00 |
TetraQ to market automated services In Australasia |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9d55fd67f1e31b9c42838a6eda2660a |
|
2007-10-29 08:27:00 |
Approval fo Second Phae I Trial for NSL-043 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cf4f68326a5658dca2c29f0f48b39919 |
|
2007-10-31 09:37:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/977ee45ec44b2c607a91df204e3e73dd |
Commitments Test Entity - First Quarter Report
|
2007-10-31 09:46:00 |
Quarterly Highlights - 30 September 2007 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d8ca4b123d44acf4941a0ba843e982e |
|
2007-11-02 14:58:00 |
NeuroSolutions to attend NeuroScience conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67d52840ff0d5d991736be79a571cf8d |
|
2007-11-12 08:37:00 |
NSL-101 Phase II Clinical Trial Receives Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/890d18b56aa53a29571e0f7cd81995e0 |
|
2007-11-22 12:34:00 |
AGM 2007 Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3e19d79e2765cb9cc23baf2e0347479 |
|
2007-11-22 12:36:00 |
AGM Chairman Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b930516954ee90f6b69949faa0bf7bc |
|
2007-11-22 12:57:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f9542155bf6cca527850ff503d4800f |
|
2007-11-22 12:59:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aea47737b68e81f8b20acaa918398de4 |
|
2007-11-22 13:01:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68090118c32cfa3e3922b379b799926e |
Change of Director's Interest Notice
|
2007-11-26 08:27:00 |
NSL-101 Phase II Clinical Trial Starts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f5cc8264adb48df208c6ea7f2aa1376f |
|
2007-11-27 11:43:00 |
NSL-101 Commencement of Second Phase II Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/add11c6af7177b49bf419cb1d9564158 |
|
2007-11-28 08:31:00 |
Sosei announces update on Phase I trials for SD118 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d341d187d9d7d6f713495677bae370d8 |
|
2007-12-17 13:00:00 |
Bioshares Research Article |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9304d49b26b209d1f4a96e47a3ee6611 |
|
2008-01-07 11:17:00 |
NeuroSolutions Enters Alliance with Argenta Discovery Ltd |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ffb0ae464ba63a53f1f2371612c9418 |
|
2008-01-08 09:34:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b0ae2b2fd65012337647745bb46ab51a |
|
2008-01-09 09:02:00 |
GSK Head of Pain Research Joins as CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0392c57a68970f7c1d2eb19a7fe628ed |
Director Appointment/Resignation
|
2008-01-10 11:18:00 |
NeuroSolutions Signs Revenue Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/04c42d8632703c2add93ea29158ea4f6 |
|
2008-01-14 13:17:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4aaf830045c071451e35effeb3fbb1a |
Change of Director's Interest Notice
|
2008-01-30 08:42:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/924555ad991dd5a116f84575ae79c367 |
Commitments Test Entity - Second Quarter Report
|
2008-01-30 08:43:00 |
Quarterly Highlights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79a9b51d89705eb34762b5d2c9650edf |
Commitments Test Entity - Second Quarter Report
|
2008-02-06 15:07:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9169742f320fcd091485987066b07d9d |
Notice of General Meeting
|
2008-02-29 11:30:00 |
NeuroSolutions signs $A1 million deal with US Pharma |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c293a731ce50d963e95143fdee40a66 |
|
2008-02-29 16:46:00 |
Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e0a74ef39de3a740133040142f98b6ca |
Half Year Directors' Statement
Half Year Directors' Report
|
2008-03-05 13:14:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b51ff6747d7e3ba29fc187a1e47f8c0 |
|
2008-03-25 14:18:00 |
NeuroSolutions Enters Research Partnership |
1 |
https://app.sharelinktechnologies.com/announcement/asx/72823467ce236d12bd89a4a50a32bdf5 |
|
2008-04-07 15:34:00 |
Research Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/366d8d909a116cb5af6f683e177bb9ec |
|
2008-04-07 19:04:00 |
CEO Commencement and Director Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4632e2d72f37106bd07b676147055236 |
Director Appointment/Resignation
Company Administration - Other
|
2008-04-08 15:09:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18dbcdd7a9c3252b5a76bd3e21e7e7b0 |
|
2008-04-08 15:11:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4204d1c981cd0ce2714a55bf054b9a81 |
|
2008-04-09 08:31:00 |
NSL-043 Achieves Phase I Clinical Trial Success |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5be532343b8d9902acae251175e42524 |
|
2008-04-09 10:18:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2067108996ceb03f7b97df1b11a182d4 |
Initial Director's Interest Notice
|
2008-04-21 10:18:00 |
NSL-043 First Phase I Trial Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/16273d3e6987657fc565fe22e932b3ce |
|
2008-04-22 08:55:00 |
NeuroNews |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68b0fa732d7aeda3e03214d256b69602 |
|
2008-04-30 14:49:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0bb3c9f0e3f603d08464a8bfb3e41df5 |
Commitments Test Entity - Third Quarter Report
|
2008-04-30 14:49:00 |
Quarterly Highlights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98d768a64d18c332db0f97d9d9c9fa3b |
Commitments Test Entity - Third Quarter Report
|
2008-06-26 16:18:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f069104a821d695950cfba17784540d |
Change of Director's Interest Notice
|
2008-07-21 08:28:00 |
Phase I Success for NSL-043 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/957860a74b75deef796385629945a82b |
|
2008-07-23 08:32:00 |
NSL-043 Phase I Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c12bf023494ecc926e6f4e4d51015848 |
|
2008-07-30 13:46:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d38341e53135658b35a4bff385b2672c |
Commitments Test Entity - Fourth Quarter Report
|
2008-07-30 15:06:00 |
Quarterly Highlights |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9e48400587eb96f08f4eea6e3e038e07 |
Commitments Test Entity - Fourth Quarter Report
|
2008-08-05 12:03:00 |
BioShares Research Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1082cad0b21f7f97dfc5ffd617d9b3c3 |
|
2008-08-26 08:24:00 |
NSL-101 effective in pain relief in Phase IIa trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a1e192aee8510aa0f8970898f56fb0da |
|
2008-08-29 11:10:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e95529fd8c9911ebb6429b4040d88adb |
Full Year Directors' Statement
Full Year Directors' Report
|
2008-08-29 11:19:00 |
NeuroDiscovery announces Full Year Result |
0 |
https://app.sharelinktechnologies.com/announcement/asx/342037dddb89419d8721e0ca0eb2ed80 |
|
2008-09-01 08:31:00 |
Appointment of Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/983af93f9e87716b173ddce7ca799153 |
Director Appointment/Resignation
|
2008-09-02 14:33:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/727db059bbc45613ae4ad12f1186126f |
Initial Director's Interest Notice
|
2008-09-03 09:26:00 |
NeuroSolutions signs $170k contract |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c7fcf5c4be6619dd2dbf389a006e723 |
|
2008-09-25 09:50:00 |
Chris Moyses appoined NeuroDiscovery CEO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8a120eaff204b118cca5b9f833c1433 |
Company Administration - Other
|
2008-09-25 09:51:00 |
Company Secretary Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1fa399128f8fbcaaa1b768a5adddc0a5 |
Company Secretary Appointment/Resignation
|
2008-09-26 08:24:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9416aa2077b0c003f8225447a34c7e6c |
Full Year Directors' Statement
Full Year Directors' Report
|
2008-09-30 09:09:00 |
CEO REMUNERATION PACKAGE |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59b9bffe63a2828abeaa4cc7f261bbae |
Company Administration - Other
|
2008-10-01 18:13:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa435f291cf2def8d9da83ef210a4432 |
Change of Director's Interest Notice
|
2008-10-17 18:46:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4adacab88fe5171cea71b58af097fa02 |
Notice of Annual General Meeting
|
2008-10-31 17:22:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7ada08a88005d41d72d49561a8010d4f |
Commitments Test Entity - First Quarter Report
|
2008-10-31 17:23:00 |
Quarterly Highlights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec77eb198b88e313abb9cc49b6dde876 |
|
2008-11-19 08:26:00 |
NeuroSolutions Presents NSL-043 Data at NeuroScience Meeting |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3124d7bad1872e733bfbbc69ee097f42 |
|
2008-11-26 14:10:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f637812e630ff5dc3e98fbc9641f7f94 |
|
2008-12-12 10:13:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6d37b10b91fca12b9256495dde8fad2e |
|
2008-12-16 09:06:00 |
UPDATE ON NSL-043 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c491cd9ed3ef272b6e40043d7c84049a |
|
2009-02-02 08:17:00 |
Quarterly Highlights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/803e5f3f6f17527a7903826c08b18494 |
Commitments Test Entity - Second Quarter Report
|
2009-02-02 08:17:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f4f9c3c4f1bcb3c6f01f729d8a973114 |
Commitments Test Entity - Second Quarter Report
|
2009-02-27 09:36:00 |
FURTHER UPDATE ON NSL-043 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/33ef38d849e10a8d88c316c294a78ffb |
|
2009-02-27 18:08:00 |
Half Year Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/28c4c8b4590550c475643c11b942740d |
Half Year Directors' Statement
Half Year Directors' Report
|
2009-03-16 08:24:00 |
NSL-043 PATENT GRANTED IN EUROPE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1a46751b609b249e83eb598b99e58062 |
|
2009-03-23 08:26:00 |
NEUROSOLUTIONS SIGNS $540k CONTRACT |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9787ac0254c057ba2da4502168db9481 |
|
2009-04-30 14:13:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d902079cc8ed4830a2641bc7b8df977b |
Commitments Test Entity - Third Quarter Report
|
2009-04-30 14:14:00 |
Quarterly Highlights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00ba8e1cd6db61f923c83a437714ea96 |
Commitments Test Entity - Third Quarter Report
|
2009-05-27 08:24:00 |
Change of Director`s Interest Notice- App3 Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6c5a4213bf8c43032433dd81dda4e79 |
Change of Director's Interest Notice
|
2009-05-29 16:33:00 |
UPDATE ON NSL-043 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d9541695ee0233b8fa049981034bf184 |
|
2009-06-09 08:26:00 |
Appointment of Director - App 3X |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93e3735f50f48e30b58b327ca14911ad |
Initial Director's Interest Notice
Director Appointment/Resignation
|
2009-06-11 11:43:00 |
Resignation of Director - App 3Z |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1121f42f0fd196fdb0ed46e692a2693c |
Final Director's Interest Notice
Director Appointment/Resignation
|
2009-06-17 08:23:00 |
Board Changes at NeuroDiscovery |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b2586a6af64d3f225f9b91475c067e1 |
Final Director's Interest Notice
Director Appointment/Resignation
|
2009-07-02 10:52:00 |
Expiry of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c599769b56c9e0da2915eb1530a32db9 |
|
2009-07-30 13:57:00 |
Resignation of Director - App 3Z |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bd59f75a40ea8c8c2e3021a76438ebb |
Final Director's Interest Notice
Director Appointment/Resignation
|
2009-07-31 11:02:00 |
Quarterly Highlights |
1 |
https://app.sharelinktechnologies.com/announcement/asx/336cb11af6116070e3abdd2dc9d67e88 |
Commitments Test Entity - Fourth Quarter Report
|
2009-07-31 11:02:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2b831692a40e280eac344860873691f8 |
Commitments Test Entity - Fourth Quarter Report
|
2009-08-06 10:54:00 |
UPDATE ON NSL-043 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48b73d8ae458dfa2dc6215cdc429dcec |
|
2009-08-06 11:02:00 |
NEUROSOLUTIONS SIGNS RECORD REVENUE CONTRACT |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00187169a5cf41736286e9fd2837d403 |
|
2009-08-21 08:20:00 |
BOARD CHANGES AT NEURODISCOVERY - APP 3Z |
0 |
https://app.sharelinktechnologies.com/announcement/asx/52d9f934aaa669ab5b30c51ed996ed69 |
Final Director's Interest Notice
Director Appointment/Resignation
|
2009-08-28 18:16:00 |
Appendix 4E - Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2d98dcc5d2c0f1ac35ccb8db4c9c9e36 |
|
2009-09-17 17:56:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/619e0fde760afd95213e26b1672fccef |
Full Year Directors' Statement
Full Year Directors' Report
|
2009-10-01 17:24:00 |
EXPIRY OF OPTIONS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8013c4e225237a8088bf4ecdfa3076b |
|
2009-10-14 18:31:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b31a12994a17bd2d6df13ec8d723e3f |
Notice of Annual General Meeting
|
2009-10-28 17:56:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad4cebb7183c93ef419174342c0019ab |
Commitments Test Entity - First Quarter Report
|
2009-10-28 17:58:00 |
Quarterly Highlights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2c48fb044a9a47cef50db3639138e3d |
Commitments Test Entity - First Quarter Report
|
2009-11-25 20:33:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fefe7fe6aedb2f61313b577ab4a2be7a |
|
2009-12-01 18:55:00 |
Expiry of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/081832dc1532bf4930d696555333ee6e |
|
2009-12-01 19:00:00 |
Change of Director`s Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da6eea8763d1fe04b5dbfd40d43272ff |
Change of Director's Interest Notice
|
2009-12-09 20:23:00 |
Correction of Expiry of Options Announcement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f8ef398fd36cf070d592f93a0b5860c |
|
2009-12-09 20:29:00 |
Revised Change of Director`s Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bbe7d385e496bbcb911295038ce18d3 |
Change of Director's Interest Notice
|
2009-12-22 08:25:00 |
UPDATE ON NSL-043 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a5a92ee51a4906c090cf6b7ec11c8ccd |
|
2010-01-29 15:01:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/44994ef1bfafee73f001b82db6a1b425 |
Commitments Test Entity - Second Quarter Report
|
2010-02-25 20:07:00 |
Half Year Accounts and Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ce49cd5b2d64c56a0583057a56dff361 |
Half Year Directors' Statement
Half Year Directors' Report
|
2010-03-17 16:23:00 |
NSL-043 and NSL-101 Clinical Programme Updates |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8471882b1a69e15692ef9580114fb38b |
|
2010-04-22 17:18:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/688b228c417c2e0c21bea58394846ef0 |
Commitments Test Entity - Third Quarter Report
|
2010-06-15 08:30:00 |
SALE OF WHOLLY OWNED SERVICES BUSINESS AND GENERAL UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1adf5f83ada728e77fc2161e76f76d15 |
|
2010-06-17 08:24:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2dbe0f370736813b73fc88d1bfd48905 |
Notice of Extraordinary General Meeting
|
2010-06-28 19:20:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82381ae936d412eb69ff2f0029988c44 |
Change of Director's Interest Notice
|
2010-07-22 17:42:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e20fe37aed3613fd3f2984dbab625e47 |
|
2010-07-22 18:51:00 |
Company Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3315ccce58fbcba0b335343ea456dfbe |
Chairman's Address - Other
|
2010-07-28 19:03:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9caac3b4d22257ae632cfd374761abd |
Ceasing to be a substantial holder
|
2010-07-29 08:22:00 |
Board Changes at NeuroDiscovery |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8aac132027a0382c160549daceed018e |
Director Appointment/Resignation
|
2010-07-29 08:23:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f40b1ea3dddd0608f53bb1db823f2eec |
Final Director's Interest Notice
|
2010-07-29 08:23:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f0d8f0c3b7fb5101483bd7d0e1ac9ec |
Initial Director's Interest Notice
|
2010-07-30 18:47:00 |
Quarterly Highlights - June 2010 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b7af9d71ac2187b33eda3d53ac555ce |
Fourth Quarter Activities Report
|
2010-07-30 19:01:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/259b16fc68d12758bee83ecc8327c7f0 |
Commitments Test Entity - Fourth Quarter Report
|
2010-08-06 14:05:00 |
Additional Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd4391b364a42dbd515ba20c5a0b14f9 |
Director Appointment/Resignation
|
2010-08-06 14:11:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e99ce3f8f341500a19133fb9d7c6689 |
Final Director's Interest Notice
|
2010-08-11 13:19:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cf021945104dcb8255a2a0162db345db |
Initial Director's Interest Notice
|
2010-08-12 08:27:00 |
NeuroDiscovery Completes Sale of Service Business |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a8ef0a815ef2caf1436f33eb40d525d |
|
2010-08-26 10:15:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a5830f937f61f4af2877ad4129d6b8d9 |
|
2010-08-26 10:46:00 |
Trading Halt Request |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60330c8cfe719db2ad8d9ddac819a49a |
|
2010-08-30 09:13:00 |
Underwritten Entitlements Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/63e5fb41000a5ba5c946ae5d32ff9fe4 |
|
2010-08-31 08:21:00 |
Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a7421261efb49d31cea97fe83a5ef9e6 |
Full Year Directors' Statement
Full Year Directors' Report
|
2010-08-31 16:59:00 |
Non-Renounceable Issue Offer Document |
1 |
https://app.sharelinktechnologies.com/announcement/asx/35bf50d8368be748c512d923b37549ba |
|
2010-08-31 17:00:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1761a1b5126db55bccb4f9198061cb3 |
|
2010-08-31 17:07:00 |
Section 708AA Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3631e031d5321f0948844cdc566d9a55 |
|
2010-09-30 08:25:00 |
Closure of Entitlements Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93019603bdc602db1ea7042c4b375ac8 |
|
2010-10-06 08:20:00 |
Allotment of Entitlement Issue Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/349c1cc596fd60a3e307aa18e2fe77ae |
|
2010-10-06 08:20:00 |
Rights Issue Cleansing Notice under section 708AA(2)(f) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b00294f0d488fdbd05b3ca42f4a66b1 |
|
2010-10-08 08:25:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b7e0b3c6e066cb8e5a05a3831c44095 |
Change of Director's Interest Notice
|
2010-10-08 08:26:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4459d5ae1c059f8dfe4af637129d9aa7 |
Final Director's Interest Notice
|
2010-10-08 08:26:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8489b27a1e1f01fd95cde52cc6867e6 |
Initial Director's Interest Notice
|
2010-10-13 08:30:00 |
Cancellation of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e950520b2c77071237362ddb9ff49703 |
|
2010-10-13 16:21:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc62ae495b763f92683afc3cc09ca5c7 |
Becoming a substantial holder
|
2010-10-14 18:48:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5fe798e327b2abcbe4c300d2d08de0d5 |
Notice of Annual General Meeting
|
2010-10-26 12:21:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b70fd6a30b124af5fa4f71ac4b45d288 |
Commitments Test Entity - First Quarter Report
|
2010-11-19 12:07:00 |
Internal Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba5b02993c9401c177260ec18e9d5d44 |
Director Appointment/Resignation
|
2010-11-24 17:33:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bfbac906af6301c3e51e8a32416649f8 |
|
2010-12-02 08:25:00 |
Joint Company Secretary Appointment / Options Expiry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abc5a5b87230a25bfdeb8d402e4cbdca |
Company Secretary Appointment/Resignation
|
2010-12-02 12:10:00 |
708 PLACEMENT |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7a904fec7f7aec74e33bcee9247398d9 |
|
2010-12-03 20:01:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3fdf0e9d29797ba83139277fb046865c |
|
2010-12-03 20:10:00 |
Section 708A Secondary Trading Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32659e6c29fa1bdfd772469d02777183 |
|
2010-12-06 18:19:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43d76afaafc0a8472f25a6950f211c72 |
Change of Director's Interest Notice
|
2010-12-06 19:35:00 |
Revised Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2918f6fd46cb3d4b8e3c85d5b498ff9 |
Change of Director's Interest Notice
|
2010-12-21 19:45:00 |
Resignation of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eebf8661e49cef5d540e987f9814ae27 |
Company Secretary Appointment/Resignation
|
2010-12-23 18:56:00 |
Securities Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b9cda6b8e385e4212e9e2b5ebcaadec |
|
2011-01-04 16:50:00 |
Change of Company Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27d9e8fba6ce95bfd0f63045a9fc47ca |
Details of Registered office address
|
2011-01-20 19:31:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9cdcfdd63de4f6f58aa6711bbc90f9c |
|
2011-01-20 20:08:00 |
Entitlement Issue and Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a94ca0ac968c34ad94597bade3f90693 |
|
2011-01-28 15:17:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6d556ee1bc5256e4c500297a633f5a94 |
Commitments Test Entity - Second Quarter Report
|
2011-01-31 14:55:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53a0778b58ff662b5192c65c69ba47cb |
Notice of General Meeting
|
2011-02-03 19:32:00 |
Non-Renounceable Entitlements Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5a2a0e1568e54940d7e86420929b86b |
New Issue Letter of Offer & Acc. Form
|
2011-02-03 19:33:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/beef9fff4ad39f88428d60249b4e08b2 |
|
2011-02-03 19:36:00 |
Entitlement Issue Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a1dba99e7f418bc41c206488a1e31454 |
|
2011-02-04 13:41:00 |
Entitlement Issue Clarification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0bcc6c9c87de0e30c849e8989a5ee3e7 |
|
2011-02-09 18:45:00 |
Supplementary Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92f04e0c941d8be6a2c4bba501dd1672 |
|
2011-02-22 15:34:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3be8e9e8da1f2ab60e2e736ab03e004b |
Half Year Directors' Statement
Half Year Directors' Report
|
2011-03-02 16:32:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03ff0e286deed1348a795c05b6a1dce3 |
|
2011-03-04 16:27:00 |
Notification of under-subscription |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca608eb7384a4efb051402fb3cffd0cc |
|
2011-03-04 17:44:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58f6fc717cebcbc6c8e0bd07a0d234fc |
Change of Director's Interest Notice
|
2011-03-08 08:20:00 |
Amended Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/617fdc989dac56a90856855b9d683698 |
Change of Director's Interest Notice
|
2011-03-16 19:49:00 |
Appendix 3B and 708 Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56bda77531e14de7652d8844fe12144e |
|
2011-04-18 12:53:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/44f5c4411106ce8bd4538657e8b7de57 |
Commitments Test Entity - Third Quarter Report
|
2011-05-23 15:19:00 |
Appendix 3B and 708 Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7514b25a2c05703f03ac7256aac6961 |
|
2011-06-28 18:46:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd8b19f8ae908b957ad92909a5047a70 |
Change of Director's Interest Notice
|
2011-07-29 16:14:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4bfa78d8c9dd78724c9c9656435a8d9f |
Commitments Test Entity - Second Quarter Report
|
2011-08-10 13:10:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1623777425f5d4ab0360900b9257b22b |
Change of Director's Interest Notice
|
2011-08-16 16:46:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/efbf92d7fbff471970732c7993195e9a |
Change of Director's Interest Notice
|
2011-08-31 17:26:00 |
Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d981c3a6284806ac095db56010de4d3a |
Full Year Directors' Statement
Full Year Directors' Report
|
2011-09-29 16:22:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04af9f11273b99a9577967efdd51fdfc |
Change of Director's Interest Notice
|
2011-09-29 16:24:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50bfb40ea3c9afdcd873fc632c8bd2d1 |
Change in substantial holding
|
2011-10-21 11:05:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3340bef474e45e54bad332e4a299f1ad |
Notice of Annual General Meeting
|
2011-10-31 14:08:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d68e9e1f25831cc223141e513daf4dc |
Commitments Test Entity - First Quarter Report
|
2011-11-23 12:59:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fca60bfb3152d69d3951a5a8c5036e48 |
|
2011-12-12 12:47:00 |
Director Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43f5dd246aa86303c251822decd03248 |
Director Appointment/Resignation
|
2011-12-12 14:38:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e91148931cc480c2a010c683b1551396 |
Initial Director's Interest Notice
|
2011-12-13 17:28:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/766aea0935aa3ef701b33362556a250b |
Initial Director's Interest Notice
|
2011-12-13 17:54:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d79a4c08751db768d7456e59e6b9047 |
Final Director's Interest Notice
|
2011-12-23 13:20:00 |
Expiry of Option |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51359e2489bbc46745d0a5cecad8df19 |
|
2012-01-03 11:51:00 |
Appendix 3B Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dcde5652fb2bf5cd48e10d7a40fa8566 |
|
2012-01-17 20:17:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56e0ddc675d4c20f1510ba9add273a98 |
Commitments Test Entity - Second Quarter Report
|
2012-01-20 19:36:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57c5177df50ad8703edab11e12af88cb |
Change of Director's Interest Notice
|
2012-02-28 13:51:00 |
Half Year Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2b8b482bb3dc6ebba5ebe4b50ec5955c |
Full Year Directors' Statement
Full Year Directors' Report
|
2012-03-14 18:53:00 |
Changes to Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/36be1c34ec3ded8435ffe978ded340fe |
Director Appointment/Resignation
|
2012-03-20 14:37:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e73ae89bffffc45d6a447f5023c22c68 |
Final Director's Interest Notice
|
2012-03-20 14:39:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b28bc1e0c2c00ba09ef1fd6adb48f5c3 |
Final Director's Interest Notice
|
2012-03-20 14:40:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5ade4077f441c3ddb2107d58b1bf877 |
Initial Director's Interest Notice
|
2012-03-23 16:13:00 |
Company Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2e1db136b15fa2020e7e193bbe3c5a2e |
Director Appointment/Resignation
|
2012-04-19 11:48:00 |
Change of Company Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6685719d47c62051920e4658c970139 |
Details of Company Address
|
2012-04-26 16:13:00 |
Appendix 4C - monthly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/172884053f9d46a1af7043f9cba25254 |
Commitments Test Entity - Third Quarter Report
|
2012-06-19 15:59:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92f541331749ad36fc6d23043989cc8c |
Change of Director's Interest Notice
|
2012-06-20 08:30:00 |
Change of Director's Interest Notice - Amended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04eee2bb0ebc6b7981704a3d59e44f03 |
Change of Director's Interest Notice
|
2012-06-21 16:55:00 |
Ceasing to be a substantial holder from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d2d46c550191eab46765dcbc5119e87 |
Ceasing to be a substantial holder
|
2012-06-22 16:24:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ff7efe4671b67958f75f8e1fb12e20c |
Change of Director's Interest Notice
|
2012-06-26 11:33:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72bea2a3e44f44460deee593776e801f |
Change of Director's Interest Notice
|
2012-06-27 09:26:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d975a4d38a08a2ddc5b846882e8578f6 |
Change of Director's Interest Notice
|
2012-07-05 11:09:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/897bb8b67c537fff67fac59cb12ea543 |
Change of Director's Interest Notice
|
2012-07-17 17:06:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7bd4716283087eb6778b72897ab1f73 |
Becoming a substantial holder
|
2012-07-31 15:30:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de0cae955cc6d9239fe248654c71dd9e |
Commitments Test Entity - Fourth Quarter Report
|
2012-08-13 18:06:00 |
Update on NSL 043 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15465562361b687023c2eac3c36a7c73 |
|
2012-08-13 18:06:00 |
Top 20 Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00fff02d569cffc56fe44541361b1870 |
|
2012-09-03 08:22:00 |
Apppendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ed148e455512bd6768b29624458a2f2 |
Full Year Directors' Statement
Full Year Directors' Report
|
2012-09-21 11:37:00 |
Diversity Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5473315eda4692328ba18ef2194db8ac |
|
2012-10-12 19:47:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e82e30631772b333282fb169f6bc234f |
Notice of Annual General Meeting
|
2012-10-22 19:03:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ef424189ec2052ef23a121a467e2819 |
Commitments Test Entity - First Quarter Report
|
2012-11-16 15:33:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/acdf7cc78ae8713a2383b76a84c728bf |
|
2013-01-30 15:52:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fcfbf625a2056054694fc127cc59f4fb |
Commitments Test Entity - Second Quarter Report
|
2013-02-04 18:21:00 |
Half Year Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b2834b940e1070df646d759aa28fd817 |
Half Year Directors' Statement
Half Year Directors' Report
|
2013-02-05 09:40:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/736552bc2797db8d4a070ad4a4007a5f |
|
2013-02-07 09:46:00 |
NeuroDiscovery to acquire Enigma Therapeutics |
1 |
https://app.sharelinktechnologies.com/announcement/asx/94bf9cbe915a6bde1199754676a46577 |
|
2013-02-07 10:54:00 |
Capital Raising Complete |
0 |
https://app.sharelinktechnologies.com/announcement/asx/862d64dc2d4929ff89c2f9350801ef0a |
|
2013-02-07 11:15:00 |
Appointment of Roger Aston |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e5bf2c25fff1b81a6fa7459441ebb42 |
Director Appointment/Resignation
|
2013-02-07 11:23:00 |
Acquisition of Enigma Therapeutics Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/416bfd2d9e244fc8ee7826a93cb9859b |
|
2013-02-07 15:32:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d1b88d5cfcf559f5e8b07df28121f41 |
Change of Director's Interest Notice
|
2013-02-15 15:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf550d2df752ea3eff17698f9b76a001 |
Change in substantial holding
|
2013-02-20 13:05:00 |
Notice of General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f3347c988099ee54a0914b85cd99054 |
Notice of General Meeting
|
2013-03-28 17:25:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/365f4af04028eaa84c52af7c15232f00 |
|
2013-03-28 17:26:00 |
Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e85c07ccfab757924001af14ddf61c56 |
Director Appointment/Resignation
|
2013-03-28 17:26:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/773d967cbd7050998f366f23bd26c8c3 |
Initial Director's Interest Notice
|
2013-03-28 17:27:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9ddd33f733c6f256418b720abdb81b2 |
Final Director's Interest Notice
|
2013-04-03 09:21:00 |
Appointment of Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e8cfc1b05e54512de98704713f51ba7 |
Director Appointment/Resignation
|
2013-04-04 13:24:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebdf94c82e948a05ef2ab6fedd7d8022 |
|
2013-04-04 13:26:00 |
708 Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6aff689a05d1953faf449d7d46e168a |
|
2013-04-04 13:27:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48f4b4e5c5f6f023c5dcee528c438024 |
Change of Director's Interest Notice
|
2013-04-04 13:28:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e226f68cd499679e253db6f4902c44b |
Change of Director's Interest Notice
|
2013-04-08 15:54:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9047762e1411e538a71fd5e7e8aedf12 |
Ceasing to be a substantial holder
|
2013-04-11 18:42:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/222610269def794a64df7c09fe037f10 |
Initial Director's Interest Notice
|
2013-04-16 15:10:00 |
Completion of Acquisition & Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45166e8e6b9f4c656100b781b26fb8ba |
Company Administration - Other
|
2013-04-17 17:16:00 |
Becoming a substantial holder x 3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15512be197e09969615700b915e766c8 |
Becoming a substantial holder
|
2013-04-19 11:52:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bbf889cffc74209af34839ff4155a73d |
Notice of General Meeting
|
2013-04-22 19:18:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0fdc1fba311ffaf01d9f6df424d20edf |
Change of Director's Interest Notice
|
2013-04-26 14:32:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/71f0f934a876c77fae07eebaf2008c17 |
Commitments Test Entity - Third Quarter Report
|
2013-05-13 08:28:00 |
Japanese patent granted |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1e8c3f14363d04f2126888d4bb51b19f |
|
2013-05-22 13:51:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d70b9dfeb192ce73afd69a2583b418b |
|
2013-05-31 18:56:00 |
Change of Company Name |
0 |
https://app.sharelinktechnologies.com/announcement/asx/682f0e92768d36c64bc1852dbb16abeb |
|
2013-06-05 12:42:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd5be04e6120d6d2ce078016f2f113d1 |
|
2013-06-05 12:43:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6aa397894718a594cb4c6992cb714a76 |
Change of Director's Interest Notice
|
2013-07-02 17:39:00 |
Appointment of CEO & change of address |
1 |
https://app.sharelinktechnologies.com/announcement/asx/080527b76fc43dccdabc3b2fead1f93e |
Director Appointment/Resignation
Details of Registered office address
Company Secretary Appointment/Resignation
|
2013-07-03 10:44:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0fa1a652db87a524ce2ca9b0db0c422 |
Initial Director's Interest Notice
|
2013-07-03 15:17:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9004b0ca91ede78e3ba147bc9de2217 |
Final Director's Interest Notice
|
2013-07-12 11:05:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/55efefccc7433b8a28da7561eee7112c |
|
2013-07-18 18:13:00 |
CEO Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b4928db51036d31f5937052422b21d6 |
|
2013-07-23 10:38:00 |
OncoSil initiates global strategic manufacturing alliance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a7050a5105bca188e13b1be6a9c86e3c |
|
2013-07-31 14:33:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/74bd9551bc3a9ef72a6297c8daf95114 |
Commitments Test Entity - Fourth Quarter Report
|
2013-08-08 13:10:00 |
US FDA Gap Analysis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c7414fa3c6d65f42a77c936e7271084 |
|
2013-08-16 12:20:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5802f32d9fba85a6a8f5abc98adcf03 |
Becoming a substantial holder
|
2013-08-16 13:11:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a6803ec3b0f0a8a4f09fc822fabbd373 |
|
2013-08-22 14:57:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c55708a77193e1c29a9f67866303a96d |
Notice of Extraordinary General Meeting
|
2013-08-23 13:18:00 |
New Financial Controller & Joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9a6a04087aca28067b06ea6801bd569 |
Company Secretary Appointment/Resignation
|
2013-08-30 19:13:00 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a39a6c49607bd28ce5a74bf2e19dee26 |
Full Year Directors' Statement
Full Year Directors' Report
|
2013-09-10 12:08:00 |
Amended Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7db596990f0fe753162b6a30e212911f |
|
2013-09-10 12:15:00 |
OncoSil Medical Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7efc8c1560f56d6cfd688fc2b74384cd |
|
2013-09-11 17:23:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/47174fbd5be9005489b8f2e8aaf9d308 |
|
2013-09-13 09:45:00 |
OncoSil raised $10million for Pancreatic Cancer Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f83bd27d5a1fdfed9eeedf496b1f6962 |
|
2013-09-13 14:04:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81b653dbb92f34a0460409727aee8252 |
Final Director's Interest Notice
|
2013-09-18 13:34:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e49466aff55faae3c4a5876dbda09c8 |
Change of Director's Interest Notice
|
2013-09-20 16:10:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2353f676e9cc5a2db7f605d0cf6d4b37 |
Notice of Annual General Meeting
|
2013-09-20 16:38:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ccd51433bbfb7f55cda417ff946026b |
|
2013-09-20 16:53:00 |
Shareholder Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32e564ac5bfcabc1a86d3b9d4da52291 |
|
2013-09-23 16:29:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c39eddc1bb6a1ff6b9088e112700b5d |
Change in substantial holding
|
2013-09-24 12:38:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf65e240ff1ca7daa4592817dfac2fb8 |
|
2013-09-24 12:40:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a5877224f1c7d88e532d5d15aa53196 |
Ceasing to be a substantial holder
|
2013-09-25 11:29:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/513f93eeb36e2d8d9ddbe37b9fcea1bb |
Ceasing to be a substantial holder
|
2013-10-01 10:21:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92c3789938a5e02e30f4405dca29529a |
Ceasing to be a substantial holder
|
2013-10-16 12:07:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2609aa9088d415a467c307a66b3a0e4 |
Change of Director's Interest Notice
|
2013-10-18 09:50:00 |
US patent for OncoSil granted by the US PTO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a614610283a7be8dcd3965eaaccf957c |
|
2013-10-23 15:48:00 |
Share Purchase Plan Successfully Completed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/653dc30dd7c434879f92f5523697fb00 |
|
2013-10-25 08:55:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/17665c29a59594ae884ae48b1107969b |
Commitments Test Entity - First Quarter Report
|
2013-10-28 09:31:00 |
Placement capacity under ASX Listing Rule 7.1 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a732b1773ac124a0e8f17bc0f54c365f |
|
2013-10-28 09:40:00 |
Chairman's Address AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4e28065f447363563347c0b97862b5b |
Chairman's Address to Shareholders
|
2013-10-28 14:46:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9ca36c5e6f98e5bf115d7e274278de6 |
|
2013-10-29 09:06:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f58e6ed43b002c26e445fdc61d0eed14 |
Change of Director's Interest Notice
|
2013-10-29 09:06:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/653f840de3e45e433dae49fa022f83c4 |
Change of Director's Interest Notice
|
2013-10-29 09:07:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56e64083ae8fdb55153e3dfc866cafc9 |
Change of Director's Interest Notice
|
2013-10-29 15:22:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2debe754070d7f2d7ad449975fd3ca8 |
|
2013-10-29 16:34:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e49f88c1ad7629f453592ff4c162e456 |
Change of Director's Interest Notice
|
2013-10-29 16:36:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/543a1a54994588b12ce96d91dda0235a |
Change of Director's Interest Notice
|
2013-10-29 17:30:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12966598d1dcd98ba688a830042bbfb2 |
|
2013-10-31 09:22:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0eb8bedf3e008098dd0359b5bb0ce61 |
Becoming a substantial holder
|
2013-11-04 16:42:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e4d35241cc419cd0b1dc4186e8a843a |
|
2013-12-03 10:36:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eba1db08d002e3b88e0e066843e3de9c |
Change of Director's Interest Notice
|
2013-12-05 09:14:00 |
Institutional Investor Presentation US FDA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3845d7e420fb535b040fc724f364ce26 |
|
2013-12-05 17:25:00 |
Amended Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b9e552f4995f6dcef94d0ccbd6d185d |
Change of Director's Interest Notice
|
2013-12-06 09:19:00 |
ASX Listing Rule 10.13.3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b35ed4ac9b64bf19902b39489874529f |
Change of Director's Interest Notice
|
2013-12-06 09:19:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d81af1fb85fe2fcdd2c065fc3468e91f |
Notice of Extraordinary General Meeting
|
2014-01-06 11:49:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f476b2d9c14d33b5b8e29b03c15282f3 |
Notice of Extraordinary General Meeting
|
2014-01-17 09:26:00 |
OncoSil Medical Ltd - Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f1428d44773b3e69bbfed015efb4b58 |
|
2014-01-29 09:41:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea6dd62ebdaccd12014dd43c0822ddc9 |
Commitments Test Entity - Second Quarter Report
|
2014-02-13 09:35:00 |
OncoSil Medical appoints Natalie Ruffles |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32434ee1708cf741671daaebcf31b93e |
Company Administration - Other
|
2014-02-20 08:42:00 |
Oncosil's next generation delivery platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d46f4947bf339f34b2b15ce22a6ac7a1 |
|
2014-02-20 11:18:00 |
Oncosil Change of Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3306a60a6adfa284851abe37feaccad6 |
Details of Company Address
|
2014-02-25 09:13:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a11e1e3b7f390d536ac4ee5ada8c3c6e |
|
2014-02-27 12:45:00 |
OncoSil Medical appoints Peter Casey joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df46ce3c25f713a9a15cc3ee04ae1a77 |
Company Secretary Appointment/Resignation
|
2014-02-27 13:27:00 |
OncoSil Medical appoints Lawrence Gozlan as Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5aa4737e98ee42d387ab08f166264f9 |
Director Appointment/Resignation
|
2014-02-27 16:17:00 |
Appendix 4D and Half Year Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cbd7edbb11916f290cf2194b340cde72 |
Half Year Directors' Statement
Half Year Directors' Report
|
2014-03-11 09:08:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/310e1f61874d3923b4710747e82d70ae |
Initial Director's Interest Notice
|
2014-03-17 08:43:00 |
OncoSil Medical commences Pivotal Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0254b79a40b80a9c9d3253ca4252f2c0 |
|
2014-03-17 19:10:00 |
Response to ASX Appendix 3X Query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20a9498ddc5b2813500eef93cc8f93bb |
|
2014-03-18 11:22:00 |
Undertakings to the ASX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b300418b81dd4143576b312e661ed23c |
Company Administration - Other
|
2014-03-19 13:07:00 |
Amended - Response to ASX Appendix 3X Query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aebff2780e3c71f076228398532a8ea7 |
|
2014-03-20 17:06:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c7aa5da83f2b002330888d6bf76bf19 |
Change of Director's Interest Notice
|
2014-03-20 17:06:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/accfb1fa6b17ccecb904d8081cfd92fd |
Notice of Extraordinary General Meeting
|
2014-04-11 09:31:00 |
OncoSil Medical Ltd - Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/52acd14e09e06a32602883ada91f1e0e |
|
2014-04-17 15:49:00 |
Release of Shares from Voluntary Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7460681befc699a4eee7ee79482ec21c |
|
2014-04-22 09:17:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2978f8de6a7f07737cbd6bc9e460041e |
Commitments Test Entity - Third Quarter Report
|
2014-04-29 11:17:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1913a54ec0a9384e36846ac431fd5d2 |
|
2014-05-08 12:20:00 |
Investor update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee3a3cb6a1b585fd2d8ea214f59f5659 |
|
2014-05-26 17:41:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f1a5fd5a67214c83bfb30ccb8aa1075 |
|
2014-07-15 09:08:00 |
Ethics Approval Granted for OncoSil in Pancreatic Cancer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2ed01a5ab18a89936ff20a07c2158887 |
|
2014-07-16 09:23:00 |
GMP manufacturing process finalised for OncoSil Medical |
1 |
https://app.sharelinktechnologies.com/announcement/asx/18e4198d0059c6a30c14799d65304094 |
|
2014-07-17 10:12:00 |
Investor Update July 2014 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5890970ad2b92368f3cc69fad3937c25 |
|
2014-07-18 10:48:00 |
Bioshares investor conference 2014 presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22278e2f6f86887ca18dd52074371c00 |
|
2014-07-31 11:29:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4e9887abbbe2c1f40b9e27c74ca7e790 |
Commitments Test Entity - Fourth Quarter Report
|
2014-08-29 09:22:00 |
Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d2ce8747cc731f4aa28cfbc8a09a1b4 |
Full Year Directors' Statement
Full Year Directors' Report
|
2014-09-09 14:46:00 |
Board and senior management restructure |
1 |
https://app.sharelinktechnologies.com/announcement/asx/08485162d359c0afa85ee2bae31dc8d4 |
Director Appointment/Resignation
|
2014-10-16 09:27:00 |
OncoSil Medical presentation - October 2014 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6571d407beb19dfb0bd2e3d5572a67f |
|
2014-10-28 09:15:00 |
Appendix 4C - Quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b2800cbe676af54f0caa706115e94954 |
Commitments Test Entity - First Quarter Report
|
2014-10-28 14:05:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d98795d0778c508a625845217dca02f1 |
Notice of Annual General Meeting
|
2014-11-11 08:30:00 |
Appointment of CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d24e82ee615c96d995026d146282d1c4 |
Director Appointment/Resignation
|
2014-11-24 10:31:00 |
New CEO receives Incentive Loan-Funded Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/797e3ca6bfefcd396fa4a250e7245dc4 |
Security holder details - Other
|
2014-11-24 16:03:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc3ac0938ae678a743e8418de2cb15a2 |
|
2014-11-28 11:56:00 |
Market Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af74337057411342072e183834be1120 |
Chairman's Address to Shareholders
|
2014-11-28 12:45:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec9435cd1d81e6ce717f059fa266a500 |
|
2014-11-28 14:28:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6606b3281e0583dad7e004d1376686ea |
Final Director's Interest Notice
|
2014-11-28 14:28:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3aaf6b47267553998a12e9a1d5bf97a |
|
2014-11-28 15:26:00 |
Director Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9cd0af1de726d275ae7ecdb5735717f3 |
Director Appointment/Resignation
|
2014-11-28 15:36:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f91769a8bd90bae0eebb06a3f7edf71 |
Initial Director's Interest Notice
|
2014-11-28 15:38:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76f63e71eedb25a6938289c4f7ac596c |
Change of Director's Interest Notice
|
2014-12-01 16:40:00 |
Share Cancellation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5a104a0f008656fc4b086e558f3f63b |
Alteration to issued capital
|
2014-12-08 17:57:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19953ecd25fbd5e117319926188bbe9f |
|
2014-12-09 11:19:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da8bb57a2c17d3bb136409120c2f14d6 |
Ceasing to be a substantial holder
|
2014-12-16 09:23:00 |
R&D Incentive Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a0e8e2b07a7779a610e981ddeca9cdd2 |
|
2015-01-27 17:06:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/067793c2c5c5955188abb9429a0374c5 |
Commitments Test Entity - Second Quarter Report
|
2015-02-25 09:34:00 |
Global Registration Plan advances |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dbf3061dec882874e103892e6c3e0f9a |
|
2015-02-26 16:36:00 |
Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e4bf5099668281706526ab03af1b0bb8 |
Half Year Directors' Statement
Half Year Directors' Report
|
2015-03-05 09:36:00 |
Investor Update March 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64c111c0bbfc9616a1ea38b276c5dc80 |
|
2015-03-16 09:20:00 |
OncoSil HCC Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/164fe6505b6f0272b86a43def5c7144a |
|
2015-04-27 08:26:00 |
OncoSil Medical ISO Certification Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3a1c33636c7b8e3eaf2cbbf09e4eaf16 |
|
2015-04-28 08:26:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f72f24b1118cd2d5ca3d4e288b1db9b |
Commitments Test Entity - Third Quarter Report
|
2015-05-04 09:26:00 |
OncoSil Medical - Director resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/696e7e38a5408e402b10eeef04081a9e |
Director Appointment/Resignation
|
2015-05-05 14:01:00 |
OncoSil Medical Investor Presentation announcement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f5deea51b31b6674e424ee12a589828 |
|
2015-05-05 14:07:00 |
Proactive Investor Presentation May 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c745d2062b447c43e757dd2a524f56a7 |
|
2015-05-11 10:14:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98d4907e52738ac41536ba8dd6c74c55 |
Final Director's Interest Notice
|
2015-05-11 11:22:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0174811263339d31c55b3ec97271f88f |
|
2015-05-18 09:52:00 |
OncoSil European Commercialisation On-Track |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2076cc9785617f7b7809437bea6cf5fc |
|
2015-05-21 09:32:00 |
Prof Pierce Chow Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3e90b3f59b5becb628b634e081e9633a |
Company Administration - Other
|
2015-06-03 10:35:00 |
OncoSil Medical - Investor Presentation June 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8704331fd6f46605ddf0c46c989f9ae4 |
|
2015-06-04 09:38:00 |
CMO appointed in lead-up to Commercialisation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d54cf9d1f409e77e82911c5c94546b42 |
Company Administration - Other
|
2015-07-08 09:14:00 |
OncoSil Medical Investor Update - July 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/637dfb2b6d159724b18296dff42d5479 |
|
2015-07-27 17:11:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d47b4215a140432a57fa6f10dd75499a |
Commitments Test Entity - Fourth Quarter Report
|
2015-08-28 17:03:00 |
Appendix 4E and Annual Report to shareholders |
1 |
https://app.sharelinktechnologies.com/announcement/asx/70734b53d64e478be0bf8115edfe2e17 |
Full Year Directors' Statement
Full Year Directors' Report
|
2015-08-28 17:13:00 |
2015 Corporate Governance Statement and Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2b4f932d35af23d337e89a26df19281d |
|
2015-09-09 08:27:00 |
EU Fast Track Review for CE Mark confirmed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b8604164d1b53719c9ad02f5a2db0ef6 |
|
2015-09-17 08:27:00 |
Change of substantial shareholder interests |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9fc4d4e8556f1237b7991a6364aa4bd8 |
Change in substantial holding
|
2015-10-01 10:35:00 |
Van Leeuwenhoeck Institute initiates Research Coverage |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b566da14bfcd7b1041a056c42b0d9a80 |
|
2015-10-08 09:15:00 |
OncoSil strengthens management team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f1e86b693ad5ea31f202cdc1c4c434f |
Company Administration - Other
|
2015-10-08 10:51:00 |
OncoSil Medical cleansing notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a325d7665fc2701aafe9dd49a419eb0 |
|
2015-10-12 09:09:00 |
OncoSil Medical CE Mark Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/abf0fc5bc944fa407319d5e206ebac26 |
|
2015-10-22 08:47:00 |
OncoSil Medical appoints new CFO Tom Milicevic |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad0a034438acd262b07e60ad85bddbbe |
Company Secretary Appointment/Resignation
|
2015-10-29 10:00:00 |
Appendix 4C - Quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8232751f782395cd946fd63810f23ec0 |
Commitments Test Entity - First Quarter Report
|
2015-11-09 08:27:00 |
Release from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7acc4cc6d9d3f54a6c38dcffe339c214 |
|
2015-11-10 12:06:00 |
OSL Voting Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d353e69a0d96f1e3bcf9d6af7a8a0f2 |
|
2015-11-10 12:15:00 |
OncoSil AGM Notice of Meeting 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4f5d25393a7ea08ed892936534c06fd |
Notice of Annual General Meeting
|
2015-11-17 10:03:00 |
OncoSil Medical's CEO presents at ASX CEO session |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45191bc56c97477f223dcb6c568f3f14 |
|
2015-11-23 16:00:00 |
Notice of initial substantial shareholder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20d13995df37e83d348132bcfc605d8a |
Becoming a substantial holder
|
2015-11-26 08:50:00 |
OncoSil Medical Interview on CE Mark and Growth Plans |
0 |
https://app.sharelinktechnologies.com/announcement/asx/463c2976a8fdd1f1a12d6f03f11497e6 |
|
2015-11-26 14:57:00 |
OncoSil Medical AGM presentation November 26th 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b1343cc7cf0f034c38ada255fcad406 |
Chairman's Address to Shareholders
|
2015-11-26 15:46:00 |
OncoSil Medical - results of the 2015 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6969ca01f95131b133c6df9f4b0b2187 |
|
2015-11-26 16:27:00 |
OncoSil Medical Appendix 3C |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db4aef8fc746ebdcc647480deded38b4 |
|
2015-11-27 10:04:00 |
OncoSil Medical - Reciept of R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0552d572d500400a8983ac5eb6e45156 |
|
2015-12-14 09:11:00 |
Appendix 3F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/861c1df786edc260e570471c975b7bf0 |
Daily Share Buy-Back Notice
|
2015-12-14 09:12:00 |
ASIC 484 (Section C) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8918274a1de7f8799cbae5709395dd5e |
Alteration to issued capital
|
2015-12-14 09:46:00 |
US FDA Investigational Device Exemption submitted |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6bf816b09421eeaefb148983b6209c1e |
|
2015-12-14 13:52:00 |
Notice of change of interests of substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/89f15cf60f2b15f728314e78519d678c |
Change in substantial holding
|
2015-12-15 09:48:00 |
OncoSil Medical appoints Charles Rowland President - USA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44e363aa6b41b02916b41b145293a0ea |
Company Administration - Other
|
2015-12-23 10:02:00 |
Appendix 3F updated |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce2a8dd13a4a881fcb8575cdc6732b18 |
Daily Share Buy-Back Notice
|
2015-12-23 10:09:00 |
Share Option Vesting Conditions Met |
0 |
https://app.sharelinktechnologies.com/announcement/asx/067ea027506bb481b8e13c05c23441b5 |
|
2016-01-07 16:17:00 |
Share Option Vesting Conditions Met |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b7f365c87ef90aa8540e82fb91dd5f7 |
Company Administration - Other
|
2016-01-13 09:54:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27ae44ce35da7087cc2520788be7e715 |
|
2016-01-21 08:48:00 |
Dr Chris Roberts - appointed Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b5a60536736e2526cfe5a7f5e47c5e6d |
Director Appointment/Resignation
|
2016-01-21 08:52:00 |
OncoSil Medical Cleansing Notice & Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d91a978e53d96ffe1e5004a8a1437848 |
|
2016-01-25 09:45:00 |
Initial Directors interest |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33b82aa2e216669d0ac734b3c586178a |
Initial Director's Interest Notice
|
2016-01-28 09:26:00 |
Appendix 4C - Quarterly Cashflow |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3baca41e2caa5ff1579ac12a6b76e27 |
Commitments Test Entity - Second Quarter Report
|
2016-01-29 09:18:00 |
Notification of change of Share Registry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d5d62ad82481c012bfd150286017b6b |
Details of Share Registry address
|
2016-02-03 09:22:00 |
$10 Million Institutional Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bd16ed2f49fe6b4abf5e4be369725c38 |
|
2016-02-09 17:21:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/243944158a93686a1a52ec03bdd28906 |
Becoming a substantial holder
|
2016-02-10 09:36:00 |
Cleansing Notice & Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c83652817055dffb28535d48bcdca57 |
|
2016-02-11 10:40:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23d75f92005089d3bcfe6cb380d41210 |
Ceasing to be a substantial holder
|
2016-02-11 10:41:00 |
Notice of change of substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95bf30d52578011cf9cb74cd03f279dc |
Change in substantial holding
|
2016-02-15 09:29:00 |
Appendix 4D & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c87096e5edb0f37e5f96562dc7b323ff |
Half Year Directors' Statement
Half Year Directors' Report
|
2016-02-25 09:16:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4159361adfaecad0ad6ae2bb9f0f31fd |
Notice of Extraordinary General Meeting
|
2016-03-01 09:30:00 |
OncoSil Market Update March 1 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e54247c4009e949ad022f5c69dcbfd39 |
|
2016-03-22 09:24:00 |
Withdrawal of Extraordinary General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f86e44ea6ac7ea6e632c949f8d2f747 |
Alteration to Notice of Meeting
|
2016-03-23 16:31:00 |
OncoSil Medical releases latest Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88e87e022b581fb6e1fc27e5b1464688 |
|
2016-04-08 11:17:00 |
OncoSil EGM Notice of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd5ff0bc191fe526f661411ac601bd38 |
Notice of Extraordinary General Meeting
|
2016-04-15 16:11:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a17f1320f5ac7e45333dfe3ea7420234 |
|
2016-04-19 09:36:00 |
OncoSil Medical Change of Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/095a870ab33646f53d3e6cee87530524 |
Details of Company Address
|
2016-04-28 09:28:00 |
Appendix 4C - Quarterly Cashflow |
1 |
https://app.sharelinktechnologies.com/announcement/asx/85ab9885097afb852f5a6d3b6ea76806 |
Commitments Test Entity - Third Quarter Report
|
2016-05-04 09:14:00 |
OncoSil Medical Presents at Asia BiotechInvest |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53c9f308341b20171dd4a90345b1dbb0 |
|
2016-05-09 14:17:00 |
Results of Extraordinary General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d5701f2cecd050ac0d6f235cea062b1 |
|
2016-05-10 10:47:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fabe98d68961d6defc270436e3935573 |
|
2016-05-13 16:29:00 |
Cleansing Notice & Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/157e27b2a4b746e2c85da41f7c06a6dd |
|
2016-05-18 09:00:00 |
Appoints Global Sales and Marketing Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3761aec492be3a76dd397aca3639091a |
Company Administration - Other
|
2016-06-30 09:34:00 |
Appendix 3B & Cleansing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4d256f6988ab18c1149ee0901ba6cc6 |
|
2016-06-30 09:51:00 |
Regulatory Update June 2016 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f5154bf83f76e7a9326e0c31121a354a |
|
2016-07-06 09:19:00 |
48th European Pancreatic Club meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07109e063454f8cf833194b5f13ef6dd |
|
2016-07-27 09:18:00 |
Appendix 4C - Quarterly Cash Flow |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8e457d713c58525cd92c3343711f41fb |
Commitments Test Entity - Fourth Quarter Report
|
2016-08-02 11:57:00 |
FDA IDE Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8cf71da3fba16812463fa33b34d86f87 |
|
2016-08-12 10:14:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/413699faa00f7aa6f5c4f44c9bb8b1e7 |
|
2016-08-18 09:33:00 |
Hot Calibration Run of the OncoSil Device |
1 |
https://app.sharelinktechnologies.com/announcement/asx/79880d099d50a10b182ced7eaed29f66 |
|
2016-08-22 08:37:00 |
Investor Presentation - Aug 2016 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24364f7b3b11654f37969822ed67c444 |
|
2016-08-30 16:04:00 |
Appendix 4E - Preliminary final report 30 June 2016 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e51b84b423215089f6c86e1bd0c48314 |
Full Year Directors' Statement
Full Year Directors' Report
|
2016-09-12 09:43:00 |
2016 Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6661e5a2dfed3e3a37594be92a4793e4 |
Full Year Directors' Statement
Full Year Directors' Report
|
2016-09-12 09:44:00 |
2016 Corporate Governance - Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/263e44e4859d61da4fa0de96573927c5 |
|
2016-09-12 10:08:00 |
2016 AGM Notice of Meeting - Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73e65cac96f0d22deedfbe26488a7b24 |
Notice of Annual General Meeting
|
2016-09-13 10:14:00 |
2016 Amended - Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0180926057805737ce8ecd8f6244195c |
|
2016-09-26 09:38:00 |
Receipt of $2.3m R & D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dee6f33776804b0d176b411463e0cdef |
|
2016-10-18 09:39:00 |
CEO Presentation - AGM 18th October 2016 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de0c3f649bee0e9ad3ed1bcfaad736a4 |
Chairman's Address to Shareholders
|
2016-10-18 13:03:00 |
2016 Results od Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/358ea6dd19edf5b7d7ef1e87c8d8f5bc |
|
2016-10-19 13:45:00 |
Final Director's Interest Notice - Martin Rogers |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a726d4ad55558221f8bfed3548d169e |
Final Director's Interest Notice
|
2016-10-27 09:24:00 |
Appendix 4C - Quarterly Cash Flow |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cda7d60d67248cbd9b81635c53ae25c7 |
Commitments Test Entity - First Quarter Report
|
2016-11-10 10:34:00 |
OncoSil Presents at Wilsons Rapid Insights Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d37a3fbbfcd54088cfaae6a38056204 |
|
2016-11-28 09:25:00 |
Pancreatic cancer clinical study update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa1712f604ac36423c96b9b4716d5cdc |
|
2017-01-20 09:12:00 |
Loan Share Vesting Conditions Met |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4ca82746d3a3cfb01a4bd23a39cb131 |
Alteration to issued capital
|
2017-01-20 15:47:00 |
Amended Escrow Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e2fb75023a510ffc428e2f40f948fceb |
|
2017-01-27 09:28:00 |
Appendix 4C - Quarterly Cash Flow |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ac92e7c62d0fb65045c483f4af5e20d |
Commitments Test Entity - Second Quarter Report
|
2017-02-02 09:18:00 |
Ethics Approval for OncoPac Clinical Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a1c5c4886c70bf340e4e89498db5ada6 |
|
2017-02-08 17:14:00 |
CE Mark Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dc2b477cfb981ed896f7c35f707f8205 |
|
2017-02-13 09:53:00 |
MHRA Approval to commence study in UK |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8637f4243539a8a748b0ea736d4b70f |
|
2017-02-23 09:56:00 |
Appendix 4D & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7222f6950b56aae21945c1529224547d |
Half Year Directors' Statement
Half Year Directors' Report
|
2017-02-28 09:35:00 |
Dr Martin Cross appointed Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/614579bded472cf0693b2600ef34f4c7 |
Director Appointment/Resignation
|
2017-02-28 17:00:00 |
Appendix 3X - Initial Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2515ee70f3a4349c0174da36d3aa8e1b |
Initial Director's Interest Notice
|
2017-03-28 09:32:00 |
First subject recruited |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8b0bb8b970af8aa603dd742749beb2d |
|
2017-04-04 09:42:00 |
UK Central Ethics Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4b96c5e2e0195da370379052bc6547d0 |
|
2017-04-10 16:04:00 |
Loan Share Vesting Conditions Met |
0 |
https://app.sharelinktechnologies.com/announcement/asx/888d9e0d02cba5b795522fe74a46ea3b |
|
2017-04-10 16:04:00 |
Notice of change of substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96f92eced86bbbbc38b1fb5e1bb8479f |
Change in substantial holding
|
2017-04-19 09:11:00 |
US IRB Approval, MD Anderson Cancer Centre |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c00ff3ed8612132a10f464545679384f |
|
2017-04-20 09:30:00 |
Specialised Therapeutics Australia supporting OncoSil study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57512151cbc9a557b79341b6b218ad69 |
|
2017-04-26 09:38:00 |
First OncoSil Device Implantation procedure completed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/419e03bc07c32720967f84572c0e633c |
|
2017-04-27 09:38:00 |
Appendix 4C and Quarterly update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6c29ec8da03fdcaa8342900b1ceb822 |
Commitments Test Entity - Third Quarter Report
|
2017-05-03 09:12:00 |
Appointment of Dr Chris Roberts AO as Chairman |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fa836e672e544c324a31b2c3f3fc2f2 |
Director Appointment/Resignation
|
2017-05-04 10:16:00 |
Dr Roger Aston, Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/36bc50652f9eaf9c32a61f170c488723 |
Director Appointment/Resignation
|
2017-05-11 09:29:00 |
Second subject recruited at Monash Health Melbourne |
1 |
https://app.sharelinktechnologies.com/announcement/asx/02590c4f31b614278a8275997db04ade |
|
2017-05-12 16:13:00 |
Cleansing Notice & Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a822f95c817ae3f769cd22e33428a1d3 |
|
2017-05-17 09:32:00 |
Change in substantial shareholder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95e0ee84dd23102359c0a174dd47ed5c |
Change in substantial holding
|
2017-07-25 09:05:00 |
Resignation of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3db2fad4a5b8b1898b4efb679d9ccd5f |
Company Secretary Appointment/Resignation
|
2017-07-31 09:32:00 |
CE Mark & Quarterly Activity Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e81e4002c9d0f58698ae0746ef903df4 |
Commitments Test Entity - Fourth Quarter Report
|
2017-08-22 09:27:00 |
First UK subject recruited |
1 |
https://app.sharelinktechnologies.com/announcement/asx/89c4f9f5fa8c4f881f0c83aaa4d17c4c |
|
2017-08-24 16:47:00 |
Appendix 4E - Preliminary Final Report 30 June 2017 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/657e03ff5cf1c89833e02eb192dae132 |
Full Year Directors' Statement
Full Year Directors' Report
|
2017-09-21 16:07:00 |
2017 Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f4346bd1fae44b60e8bb450b5b6c3aa1 |
|
2017-09-21 16:08:00 |
2017 Oncosil Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfc8eca36e1a65ced962102dab0aa759 |
Full Year Directors' Statement
Full Year Directors' Report
|
2017-09-21 16:12:00 |
2017 Notice of Meeting and Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54c8e0911ccb4bcf836a24a1f56dea5a |
Notice of Annual General Meeting
|
2017-09-22 09:33:00 |
Progress update on Global Pancreatic Cancer Clinical Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/77356cc727173a6d698c91fc3b9f4a29 |
|
2017-09-25 09:22:00 |
R&D Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2891fdfddd62ebca74f9b3182da8f124 |
|
2017-10-16 09:36:00 |
Progress Update on Global Pancreatic Cancer Clinical Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2f9d72fa4c97c1ab6a6db4371e3017b4 |
|
2017-10-23 09:06:00 |
Positive Early Study Results Presented at EANM Congress |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7175fc2b128c2d4be855fe6d189215fe |
|
2017-10-24 09:13:00 |
Australia Biotech Invest 2017 Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32bd2240c7d11d94787502c6defb10a0 |
|
2017-10-25 15:21:00 |
Results of Annual General Meeting 2017 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c9b0226050f4fa01a97812f37711986 |
|
2017-10-26 17:33:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b1948a0c0cb921cab5d6d5c79f38fd2 |
Change in substantial holding
|
2017-10-31 09:22:00 |
Appendix 4C & Quarterly Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7e9bc5b9d01e8b4774748d2953c59eee |
Commitments Test Entity - First Quarter Report
|
2017-11-23 16:16:00 |
Loan Share Vesting Conditions Met |
0 |
https://app.sharelinktechnologies.com/announcement/asx/224b6a45568282c6002a5cc95c6441b0 |
Alteration to issued capital
|
2017-12-21 09:33:00 |
Progress Update on Global Pancreatic Cancer Clinical Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/369f93dc3985dd02fc3190d86d96385c |
|
2018-01-10 09:35:00 |
20th Patient implanted with OncoSil device |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d62ea02ea4bf5d57e1c25cee7abf7e24 |
|
2018-01-11 09:24:00 |
Appendix 3C - Employee Loan Share Buy Back |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d985660542e7ee59c7fd52b3ac7d9a8e |
|
2018-01-16 16:40:00 |
Additional Receipt of $0.6m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9c98712efcc0f6d0da5d031be984d771 |
|
2018-01-29 09:34:00 |
Appendix 4C & Quarterly Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/221dc8baebb41f14df1acdbfd1249105 |
Commitments Test Entity - Second Quarter Report
|
2018-01-30 09:04:00 |
Final share buy-back notice - Appendix 3F |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48ad9dc1aee421b92c5152139c6e12fa |
Daily Share Buy-Back Notice
|
2018-01-30 13:15:00 |
Change of Director's Interest Notice - Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a91d4e1608db659706966273865aa2c |
Change of Director's Interest Notice
|
2018-01-30 13:16:00 |
Change of Director's Interest Notice - Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cb8da90a15e9e61886545da2b8c3033 |
Change of Director's Interest Notice
|
2018-02-08 09:29:00 |
Response to ASX Appendix 4C Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0e4d84323940ec7cfdbc005c779f5503 |
|
2018-02-08 09:40:00 |
First Subject Recruited in the United States |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ac9bb9fbf4b50a571f552c02f088b551 |
|
2018-02-08 17:23:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f8ebb592cb8a777af3a6ddfa890aa18 |
Change in substantial holding
|
2018-02-21 11:59:00 |
Appendix 4D & Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7b147a4c752a8725b9667661516cfe40 |
Half Year Directors' Statement
Half Year Directors' Report
|
2018-02-28 09:20:00 |
Positive Early Study Results Continue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5987ba998a846f1c7a02600567392cd4 |
|
2018-03-02 15:53:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb487a00807b7022474376d0aa645579 |
|
2018-03-08 09:18:00 |
OncoSil Company Update Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0bbac79ac4a1d61fed470d31f21dce29 |
|
2018-03-21 09:20:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1bbf506893eec19a8769e26c9dfb1f9 |
|
2018-03-21 09:39:00 |
Surgical Resection Outcomes and Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fecc3656c670a6e381dc531551cb7217 |
|
2018-03-21 09:44:00 |
Presentation-Surgical Resection Outcomes and Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3d2f3726e850aefbe3f042ebfde920aa |
|
2018-03-22 12:10:00 |
Successful Completion of Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0d077967faf989cbe8069a2092475599 |
|
2018-03-28 09:29:00 |
Cleansing Statement & Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ff9d73f53b4f84afb5d690def2b989d |
|
2018-03-28 09:56:00 |
Oncosil Medical Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a907d13a6988a3f448f17c6c88e81382 |
|
2018-03-28 12:20:00 |
Ceasing to be a substantial holder for OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/630b4dba08c20517b167b73db38833eb |
Ceasing to be a substantial holder
|
2018-04-03 13:55:00 |
CEO Interview - Clinical data update and outlook video |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bddf058a2fcd8c69579ee750b2aa4a8c |
Company Administration - Other
|
2018-04-03 17:12:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a9b22c7ba924b146b951078d80bc3b4 |
Change in substantial holding
|
2018-04-04 09:45:00 |
Clinical Programme Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/60954b58874ed98f09229b7789792ab7 |
|
2018-04-09 09:02:00 |
Oncosil Medical presents at Proactive Investors CEO Sessions |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7bf5b83c06533ddede01d04ad008ece7 |
Company Administration - Other
|
2018-04-11 16:09:00 |
Oncosil Medical Share Purchase Plan Closing Date Reminder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0cf475ff3479fa5e060d3b829cb0138 |
|
2018-04-13 12:26:00 |
EGM Notice of Meeting & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa051d6cf3bb9d8b03ae2b4ee7953075 |
Notice of Extraordinary General Meeting
|
2018-04-19 10:06:00 |
OncoSil Medical raises $4.0m from Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca32aed8127c61b72bed5aba444f86d4 |
Alteration to issued capital
|
2018-04-20 08:41:00 |
ASIC Form 484 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c579884e12ad18652ca9af87709a614f |
Alteration to issued capital
|
2018-04-20 12:18:00 |
Appendix 3B - Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd13e613bf0ca71a62e6c3f86f35fcc3 |
|
2018-04-26 10:15:00 |
Appendix 4C & Quarterly Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/887fdd4c7889bd7248793ae1f442d5e6 |
Commitments Test Entity - Third Quarter Report
|
2018-04-26 16:14:00 |
Appendix 3Y - Dr Chris Roberts Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae715b74f7ef72f9ef809d07667b3893 |
Change of Director's Interest Notice
|
2018-04-26 16:16:00 |
Appendix 3Y - Daniel Kenny Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f737d951fe0064c4a27e5f21369c83d2 |
Change of Director's Interest Notice
|
2018-04-26 16:17:00 |
Appendix 3Y - Dr Martin Cross Share Purchase Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f02e1fa8df23e1778bc66a00c649c2f0 |
Change of Director's Interest Notice
|
2018-05-02 09:09:00 |
OSL to present at Finance News Network Investor Session |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0bdc40f1c2533441f4ed2a7e14bae5a9 |
|
2018-05-14 09:02:00 |
Oncosil submits Clinical Study Report to Notified Body |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2f04252604e36ce8cad49961ad04f101 |
|
2018-05-14 12:40:00 |
Results of Extraordinary General Meeting 2018 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a31972eaf730eb86e3be2842de9b8987 |
|
2018-05-17 15:34:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0eff13af8a6ba30481985ef0d055020a |
|
2018-05-18 09:48:00 |
Appendix 3Y - Dr Martin Cross |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31c8929a1af1db1d64950870634ede9a |
Change of Director's Interest Notice
|
2018-05-18 09:49:00 |
Appendix 3Y - Dr Chris Roberts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad8b7dce62effc62233149a6ef615e7c |
Change of Director's Interest Notice
|
2018-05-18 09:50:00 |
Appendix 3Y - Dr Roger Aston |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90dbf1e300a277e6d57f475e13f524e3 |
Change of Director's Interest Notice
|
2018-05-31 15:26:00 |
Response to Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0507a7bd59702ad0e989f45fe792e6fb |
|
2018-06-04 09:23:00 |
OncoSil Company Update Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/575a2cbb59f4edeef2dbbbd40a66fd2b |
|
2018-07-05 09:59:00 |
OSL to present at Monsoon Communications Investor Event |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e3113f30d47cd4539b1e49f96179296 |
|
2018-07-25 09:47:00 |
Appendix 4C & Quarterly Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4478c7c196ceba47831916ebdbe5a4c5 |
Commitments Test Entity - Fourth Quarter Report
|
2018-07-26 09:07:00 |
Oncosil Company Update Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f161959cd7882fc94b82c6fbecd1e90 |
|
2018-08-22 16:11:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f54e74bfa429abc1d5c4838fd727804 |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-08-30 08:44:00 |
IQVIA appointed EU Market Access and Reimbursement Advisor |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8acb60a1fb98a3b947bd0aa618a36f93 |
|
2018-09-24 10:02:00 |
R&D Refund - 2018 Financial Year |
1 |
https://app.sharelinktechnologies.com/announcement/asx/171d563a52b2e41d767dc181f23c50e7 |
Company Administration - Other
|
2018-09-28 08:31:00 |
2018 Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c87c0d4abbb62b43cdca09981831b9c |
|
2018-09-28 08:38:00 |
2018 Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/909048f201980f63d45c19cc16e191c6 |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-09-28 08:39:00 |
2018 Notice of General Meeting & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5288302b27e239459b5b7b922fbf1a2b |
Notice of Annual General Meeting
|
2018-10-25 09:20:00 |
PanCo Study Interim Analysis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f58670fc426e5177e41b7df8a12899f1 |
|
2018-10-29 08:38:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/715ecc6971a28d6b04c138fa323e7178 |
Commitments Test Entity - First Quarter Report
|
2018-10-30 09:33:00 |
2018 AGM CEO Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0322776997519d144668bee40503307 |
Chairman's Address to Shareholders
|
2018-10-30 14:09:00 |
Results of Annual General Meeting 2018 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bd3e2000a93971976ee01e63083c52b |
|
2018-10-30 17:27:00 |
Results of Annual General Meeting 2018 - Amended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/070114eaabf785814f96a5b79b02223b |
|
2018-10-31 09:56:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c22c7edbfb0f609e21f5085691fbcfd2 |
|
2018-11-02 09:49:00 |
Loan Share Vesting Conditions Met |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5fcd115e78fd113d7aa7131235e2090 |
|
2018-12-10 09:43:00 |
Director Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/105ce2f3e2459f2f96e03a51fc564498 |
Director Appointment/Resignation
|
2018-12-11 12:30:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b4935edc10a44fe030c237b09853f53 |
Initial Director's Interest Notice
|
2019-01-31 09:34:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7fd4a7087e181f43784b68b57123c6eb |
Commitments Test Entity - Second Quarter Report
|
2019-02-20 10:04:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3062eea23d9b0558ff9af7dee8dacf0f |
Half Year Directors' Statement
Half Year Directors' Report
|
2019-03-25 09:31:00 |
CE Marking Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fca52e417e9280170501d1bed21caed2 |
|
2019-03-29 09:45:00 |
Update - CE Marking Application |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1c4e99e8d60ef9a8f9cc65e797436787 |
|
2019-04-02 10:18:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/423bf74a3baa0955914402314b43d2ab |
Change of Director's Interest Notice
|
2019-04-18 09:45:00 |
Loan Share Vesting Conditions Met |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2117fa2a1f716243243dba8781b87bc1 |
|
2019-04-30 09:32:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98e5fdc616ffeca984d36fa6497fcdf6 |
Commitments Test Entity - Third Quarter Report
|
2019-05-03 09:11:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc76d3f18a64ba8f9f836fd01cea6c36 |
Change of Director's Interest Notice
|
2019-05-09 16:55:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6ba365032d71439e4752329fa05f66c |
Change of Director's Interest Notice
|
2019-06-04 08:54:00 |
Positive Overall Survival data released at ASCO 2019 Chicago |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b6ec4240fca79f95c8a7024f332e6c5 |
|
2019-06-28 17:07:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c747b659a36361e4188296e44264beee |
Change in substantial holding
|
2019-07-02 08:21:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75646c88a82fcb6806b02e5b76e51bb0 |
Becoming a substantial holder
|
2019-07-02 08:22:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e415da4e0c3d4812735108b775261ab7 |
Ceasing to be a substantial holder
|
2019-07-26 13:38:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/849035aa68b09625a91a607c9d69b704 |
|
2019-07-30 16:53:00 |
CE Marking Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/035c3d9253148cbfbcc5bfed12209411 |
|
2019-07-31 09:16:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c10563f23a4cc9e20ef2baf8296cea64 |
Commitments Test Entity - Fourth Quarter Report
|
2019-08-23 09:43:00 |
Appendix 4E and Full Year Statutory Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/22f16d9379bb89d78e83a971097b4835 |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-08-28 17:13:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/161534127cbe873af1b3287a73642ca2 |
Change of Director's Interest Notice
|
2019-09-09 16:18:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7f8b39cda3955ead205275a961b9585 |
Change of Director's Interest Notice
|
2019-09-11 08:47:00 |
Change of Director's Interest Notice - Amended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8f2141790b1cff77ba209235b8924ae |
Change of Director's Interest Notice
|
2019-09-11 08:48:00 |
Change of Director's Interest Notice - Amended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62e85e4e999b12313700bb3c81a0a249 |
Change of Director's Interest Notice
|
2019-09-27 09:47:00 |
2019 Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45f53d0ab9fc290753af0f9ed4adcf06 |
|
2019-09-27 09:53:00 |
2019 Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e54073f15b28e8273f9f37e2c2ef1ec3 |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-09-27 09:53:00 |
2019 Notice of General Meeting & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7d3cdf4cd7c684637b36a0d03833b07 |
Notice of Annual General Meeting
|
2019-09-30 09:29:00 |
Changes in Senior Management |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9b6a4322af4258767e1005e71119e8f |
Company Secretary Appointment/Resignation
Company Administration - Other
|
2019-10-11 09:35:00 |
Positive Regulatory Updates |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d559a411bcd73ee790bb92afe1e8c79 |
|
2019-10-18 09:03:00 |
Receipt of $3.8M R&D Tax Incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4af7ffee7c37e3e582277567d356ddc0 |
|
2019-10-28 19:39:00 |
Updated Clinical Evaluation Report to BSI |
1 |
https://app.sharelinktechnologies.com/announcement/asx/70ffc6fb4dc0f7f35b3b2116a9378d72 |
|
2019-10-29 08:34:00 |
OncoSil AGM CEO Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fea1a98f46caafb03ec81bb2f18ad917 |
Chairman's Address to Shareholders
|
2019-10-29 13:22:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e81597190afbf01ba17d8506eff069a |
|
2019-10-31 09:26:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/08c111b11d9112132dc04809a1756d22 |
Commitments Test Entity - First Quarter Report
|
2019-11-01 09:15:00 |
Positive CE Mark Status Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f3d543be5042e7184e7d47c2246b96f3 |
|
2019-11-15 08:17:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e86080a5f6296b4a4eaaa8af59af911 |
Becoming a substantial holder
|
2019-11-19 08:15:00 |
CE Mark Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e41f05a74b1a00a155f409bff28b7ea |
|
2020-01-24 14:29:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9947aab10aae5f569b2cf5b31c7a6de1 |
Change in substantial holding
|
2020-01-30 08:55:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b66560baf9761fb9ac9e2411b90641fb |
Commitments Test Entity - Second Quarter Report
|
2020-02-18 17:13:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39048a0f201a19c92d6f823d759ffb2b |
Change in substantial holding
|
2020-02-21 16:46:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ed9937ac8caf7b34b1a4533b02c1c75 |
Ceasing to be a substantial holder
|
2020-02-27 08:26:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5df5bfa4bd288507fff61070e319e715 |
Half Year Directors' Statement
Half Year Directors' Report
|
2020-03-11 10:49:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40ae32997e7dfbb0b319405f7c8cd756 |
Change of Director's Interest Notice
|
2020-03-18 08:48:00 |
FDA Grants Breakthrough Device Designation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e4cd73c6c41af89219a2b92c2b744059 |
|
2020-03-18 09:24:00 |
Becoming and changing substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfc221162c1f34d60a81f93cc357c023 |
Becoming a substantial holder
Change in substantial holding
|
2020-03-25 18:45:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39b873ca1423e54619e73888a8da6c5b |
Appendix 2A (Application for Quotation of Securities
|
2020-03-27 09:15:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/694f43afd46d2367a5da2e30cbe73d77 |
|
2020-03-27 12:56:00 |
Pause in Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cc953ef76d9a9e6fb921595d65bfb126 |
|
2020-03-27 13:49:00 |
Clarification Statement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aafaa9648c9257cc7fc5e603e79bc4e4 |
|
2020-03-31 18:05:00 |
Appointment of CFO and Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/746e6b0bb7cb90a55e8874dec3e7ea77 |
Company Secretary Appointment/Resignation
Company Administration - Other
|
2020-04-01 08:29:00 |
Oncosil breakthrough device receives CE Marking approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/371b65f18838b4c49f7f3b4559781405 |
|
2020-04-07 08:07:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cdb722238bc3af9ec72d501a6711e46e |
Ceasing to be a substantial holder
|
2020-04-16 15:50:00 |
Shares forfeited and cancelled |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6e3d86084b69f7c7318b2dcf4961f7b |
Alteration to issued capital
|
2020-04-29 09:15:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1aadb33786880f2d32ff53132e4e167 |
|
2020-04-30 17:09:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2aa1291b5558a63eefff392e37e01dcc |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2020-05-04 09:02:00 |
OncoSil appoints Nigel Lange as EMEA President |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31425989ad0ded450f54ac2b124e6e5f |
Company Administration - Other
|
2020-05-04 09:03:00 |
OncoSil submits for ASEAN and APAC approvals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40cac036ebab9b14a2ac998d7ee87b57 |
|
2020-05-04 09:04:00 |
OncoSil to present at Virtual Health Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fef61a2769fa75d1e7e0177fb2992d8c |
Company Administration - Other
|
2020-05-04 09:28:00 |
OncoSil launches Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7677ab58528ff0ed79e15383327f591f |
|
2020-05-04 09:29:00 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7b1a1e38a8c89fa97b81f37e8481af84 |
|
2020-05-04 09:30:00 |
Cleansing notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/593d09a3e637ba358ddc65e6feb7443e |
|
2020-05-04 09:31:00 |
Letter to ineligible shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d386c57bc6d070cb72e3c3558899d54c |
|
2020-05-04 09:32:00 |
Proposed issue of Securities - OSL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97e2f7064c6bbaea622f97b35f2b337f |
|
2020-05-08 09:24:00 |
Allotment of Securities under Institutional Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f08e7a0a05e8d85c340dacdfd3753db1 |
|
2020-05-08 09:25:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58fdf19346cf7d8d94d91859c4e240f4 |
|
2020-05-08 09:26:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ce17f27a25ae69e25861092e8968d7d |
Appendix 2A (Application for Quotation of Securities
|
2020-05-08 18:22:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3802faece5d68b9f38501b07a69ba08d |
Ceasing to be a substantial holder
|
2020-05-12 09:20:00 |
OncoSil Entitlement Offer Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/66ff66452ea4bd854c4cfc67075cf127 |
|
2020-05-12 17:17:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ddded8ca0c61fe1730f3796f8422fd25 |
Becoming a substantial holder
|
2020-05-13 13:56:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd70f0e0468ce3023a0b4f680f9f49e9 |
Becoming a substantial holder
|
2020-05-19 16:56:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85cdc756e4b222ef1a387c994340f41c |
Ceasing to be a substantial holder
|
2020-05-26 09:20:00 |
Entitlement Offer Results and Shortfall Notification |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8597ab14381aa0bf435ad8f289d92b08 |
|
2020-05-26 18:40:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63b076f2a20e3589871800fbf4c3db16 |
Ceasing to be a substantial holder
|
2020-05-28 10:17:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4babc1a50f910b204a4813609b43830a |
Appendix 2A (Application for Quotation of Securities
|
2020-05-29 18:01:00 |
Appendix 3Y - Late Lodgement Notice - Roger Aston |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76498aa952e38f04b1f32f24bdae08af |
Change of Director's Interest Notice
|
2020-05-29 18:01:00 |
Appendix 3Y - Late Lodgement Notice - Daniel Kenny |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6cf849b0b3472ecf1fe61bcf44d21d17 |
Change of Director's Interest Notice
|
2020-05-29 18:01:00 |
Change of Director's Interest Notice - Chris Roberts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd667030632337f344201b105cb858c9 |
Change of Director's Interest Notice
|
2020-05-29 18:01:00 |
Change in substantial holding - Daniel Kenny |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5d0c3aacf2a24922c111cb6e4957fab |
Change in substantial holding
|
2020-05-29 18:01:00 |
Change of Director's Interest Notice - Martin Cross |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a6de76d8b56e73ccd2243efe323edab |
Change of Director's Interest Notice
|
2020-05-29 18:02:00 |
Change of Director's Interest Notice - Michael Bassett |
0 |
https://app.sharelinktechnologies.com/announcement/asx/490d312f3a5fb5d63b3303c0ab892ce9 |
Change of Director's Interest Notice
|
2020-05-29 18:17:00 |
Change of Director's Interest Notice - Roger Aston |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5028c453466277f80c62093940f9d4b2 |
Change of Director's Interest Notice
|
2020-05-29 18:19:00 |
Change of Directors Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e3cd760b6bec3eec0ee9e9dbc12a588 |
Change of Director's Interest Notice
|
2020-06-01 08:42:00 |
OncoSil receives Singapore regulatory approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e84c6bed16431549b5df402bce8ac6ab |
|
2020-06-30 16:37:00 |
Cancellation of shares under the Employee Share Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebb7c7fc96d004ca6f89db1de4619256 |
Alteration to issued capital
|
2020-06-30 16:46:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7312f118297b6e9b20255975cee62c85 |
Change of Director's Interest Notice
|
2020-06-30 16:46:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2c44e006a252dfdc62089c70da336d2 |
Change of Director's Interest Notice
|
2020-07-02 09:06:00 |
OncoSil files for TGA registration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a31e37efd72debfec5f8f0c99a7f0c3d |
|
2020-07-03 09:45:00 |
OncoSil presents clinical data at ESMO World Congress |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f70638666f048ca20ea22c892d2e3e77 |
|
2020-07-28 08:22:00 |
HDE filing submitted in US for Bile Duct Cancer treatment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2fa010e60f79a8c26668c8a46e55da43 |
|
2020-07-30 08:33:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6f5b835261ed0742d5bf23faf0dfaff |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2020-08-07 17:01:00 |
Clarification of June Quarter Appendix 4C |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5d3e43a7f2e39e99c63c8e7797b79715 |
Commitments Test Entity - Fourth Quarter Report
|
2020-08-19 19:22:00 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6b072df4380c1213996046fe2c9a4aa |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-08-19 19:23:00 |
Preliminary Final Report - Appendix 4E Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2984bf4b35c4c43e984f6bd81065cf1 |
|
2020-08-19 19:24:00 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1886be2a4dff63ac4bc7f1e6ffd3e46a |
|
2020-08-28 08:17:00 |
OncoSil receives Malaysian regulatory approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d4688f5691d903038f4d87109f6eb99b |
|
2020-08-28 11:23:00 |
Investor Update - Conference Call Notification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0efd6b184d3a891c71bcca748bdfec32 |
|
2020-08-28 11:24:00 |
Investor Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ca19fd367499252f03ca0f44dbabb1dc |
|
2020-09-18 16:20:00 |
2020 Notice of General Meeting & Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49b2b688d807d71aa89e96a3ad458674 |
Notice of Annual General Meeting
|
2020-09-23 09:13:00 |
Receipt of $2.8m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/063993fadc891fa2fdee2600bb5ba643 |
|
2020-10-20 08:38:00 |
2020 AGM Chairman's Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/adf4f6499e72d9443d36feb05fe6e054 |
Chairman's Address to Shareholders
|
2020-10-20 08:40:00 |
2020 AGM CEO Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7973f1f1a6517268cde70bf1ba043be3 |
Chairman's Address to Shareholders
|
2020-10-20 08:41:00 |
Positive PanCO trial update on resected cohort |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0631ef1048114b415587bddd5ceca5f8 |
|
2020-10-20 17:44:00 |
Results of the OncoSil 2020 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90e84e6f5c8eea10d2f208c5b4b7b1df |
|
2020-10-21 15:44:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/551842c9f583ba263ea032febf9db071 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2020-10-22 08:35:00 |
OncoSil achieves first commercial sale |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8377eb44961c9f60eda2ec505c396a30 |
|
2020-10-27 14:42:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6cb56e2a0b864545af3c6fdcb71ce7b1 |
Change of Director's Interest Notice
|
2020-10-29 09:30:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/364df0351520ddcce59d4178453cccbe |
Change of Director's Interest Notice
|
2020-11-05 09:57:00 |
OncoSil receives Swiss regulatory approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/013e038911a75429ca75287d4128b507 |
|
2020-11-05 13:02:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4069cb0047f3cef3ab9c5a364f3ba450 |
Appendix 2A (Application for Quotation of Securities
|
2020-11-05 15:59:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60425d07692cb8346686a0838321e9c7 |
Change of Director's Interest Notice
|
2020-12-02 09:29:00 |
Termination of Mr Daniel Kenny as Chief Executive Officer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3a2065138de70873599f49d663c4afd2 |
Director Appointment/Resignation
|
2020-12-18 17:57:00 |
Cancellation of shares under the Employee Share Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c05ebfeb5623d60b5bb6444eca2fbeb |
|
2020-12-18 17:58:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ce64ca02325225e472ad624122b82a0 |
Change of Director's Interest Notice
|
2020-12-18 17:59:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f4bf9f1e616fd0ee818b62d6a623058b |
Final Director's Interest Notice
|
2020-12-18 17:59:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d43c1959f50c2228d1378000217d14df |
Change of Director's Interest Notice
|
2021-01-18 16:10:00 |
OncoSil FY21 half yearly review |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2eeb10b9ea4f6b298fd84dba757862ae |
Company Administration - Other
|
2021-01-21 16:09:00 |
Appointment of Chief Executive Officer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97fce76b3d85a7c6d12341a816b1b9de |
Director Appointment/Resignation
|
2021-01-21 18:11:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc9f2d44d416ea721ba2927db718a9df |
Initial Director's Interest Notice
|
2021-01-28 09:31:00 |
Cancellation of shares under the Employee Share Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c2c541052f64f77ac858967d3e2d002 |
Alteration to issued capital
|
2021-01-28 17:05:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c3fd68c057237e6dd54989343eb32a1e |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2021-02-10 16:30:00 |
Appointment of Chief Medical Officer & Medical Affairs Head |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42043d9072c115861d8b5040782fb381 |
Company Administration - Other
|
2021-02-16 16:50:00 |
Business Update - Conference Call Notification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b55e605fe878491604748a9b1dc7970a |
Chairman's Address to Shareholders
|
2021-02-18 10:05:00 |
OncoSil Investor Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2505acf73adc657f1165b49ef87e43ce |
|
2021-02-23 12:15:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d8b8f468b50538e80c27fae405deb553 |
Half Year Directors' Statement
Half Year Directors' Report
|
2021-02-23 12:15:00 |
Half-Yearly Report Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1959eef55ea03cfcbafbfe4781ae82a3 |
|
2021-02-26 08:12:00 |
Business update call transcript |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79e5622e19ec0ddf066ae33927fbb910 |
|
2021-03-01 09:09:00 |
Change of Registered Office and Principal Place of Business |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e260cba9e8184ed74cc6015afafb35be |
Details of Registered office address
|
2021-04-29 17:09:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15d2f08b1d0d791cf09cc61153ee49da |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-05-04 15:19:00 |
OncoSil receives regulatory approval from Hong Kong |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13a8c785a5610a82ead9d9245e6baeb3 |
|
2021-05-10 16:06:00 |
Cancellation of loan funded shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44a0c466f4c96d2d863ec11a9654c41d |
Alteration to issued capital
|
2021-05-10 16:06:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/502c98eaff55b6a85fc24fa3407711ad |
Change of Director's Interest Notice
|
2021-06-02 15:50:00 |
OncoSil TGA regulatory update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1418207751101257e6348643f60f4040 |
Company Administration - Other
|
2021-07-20 09:42:00 |
Otto Buttula appointed to the Board of OncoSil |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca397eee5e63d754757a2b45efd5645e |
Director Appointment/Resignation
|
2021-07-21 09:47:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc99a92d1a5c19b32e46d0f1fa5b240b |
Initial Director's Interest Notice
|
2021-07-26 08:56:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/139c704742bfb2dd5bb4b2df64850409 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2021-08-11 16:13:00 |
Cancellation of shares under the Employee Share Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e8e787939db1bb195ca6a13b1e9ddfd |
Alteration to issued capital
Company Administration - Other
|
2021-08-19 09:29:00 |
Appendix 4E Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dc9bb94f3e074d2532cbc59c762c8365 |
|
2021-08-19 09:29:00 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e6d164762d486128b2b59c851c0d117a |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-08-19 09:30:00 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/10be66f7da464e939a586204596b4da0 |
|
2021-08-25 09:54:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e97d9d9612ab34bce69617796f17f245 |
Change of Director's Interest Notice
|
2021-09-17 16:06:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33cd625fb28334b01d5e641440d19ac7 |
Notice of General Meeting
|
2021-09-27 08:53:00 |
Receipt of $1.077m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a64ad57f385b4676476e37621fcdd1ce |
|
2021-10-12 10:43:00 |
Prof. Ricky Sharma appointed to the Board of OncoSil |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72298c37437627d028207ae02392afcc |
Director Appointment/Resignation
|
2021-10-19 09:27:00 |
Resignation of Director - Dr Roger Aston |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df9c3003d8fcd21bd25acd55a960e780 |
Director Appointment/Resignation
|
2021-10-19 09:31:00 |
2021 AGM Chairman's Address |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b4f206e8ddd68c02200d3651ab276651 |
Chairman's Address to Shareholders
|
2021-10-19 09:34:00 |
2021 AGM CEO Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3bcffdd8834ec53673c63a4592199e8 |
|
2021-10-19 18:07:00 |
Results of the OncoSil 2021 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3bb97c75b95b6efe72b8ebd501a7393d |
|
2021-10-19 18:11:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b05308adaa9ead0ea6e24fab09fda503 |
Final Director's Interest Notice
|
2021-10-20 17:20:00 |
Issue of Performance Rights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/588c50ed99fadffe338a401d05b51c20 |
Company Administration - Other
|
2021-10-20 17:21:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0076d83872f3330c9cd814c733707061 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-10-20 17:25:00 |
Final Director's Interest Notice - Dr Chris Roberts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/14a3d0e958262bc9f9312fe90ce247db |
Final Director's Interest Notice
|
2021-10-20 17:26:00 |
Final Director's Interest Notice - Mr Michael Bassett |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc516b4fad03db6032c19ea3416c2aaa |
Final Director's Interest Notice
|
2021-10-20 17:27:00 |
Change of Director's Interest Notice - Mr Nigel Lange |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd2116ab976cf6f89ea18921e5910acc |
Change of Director's Interest Notice
|
2021-10-29 09:48:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c66cc28ff217b8e9bf156cf5b7b0f6ce |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2021-11-01 18:22:00 |
Jobkeeper Payments Notification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e80dad0b42bf8bc746adf4288e9715c |
|
2021-11-01 18:24:00 |
Initial Director's Interest Notice - Prof. Ricky Sharma |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61c66710cc460a947a8b54759a27c348 |
Initial Director's Interest Notice
|
2021-12-24 09:00:00 |
PanCO Clinical Study on OncoSil Published in ESMO Open |
1 |
https://app.sharelinktechnologies.com/announcement/asx/81ee6a0379836059a292873b79171449 |
|
2022-01-31 08:30:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9e1e9cf52ed1c124486b74bff866b9a1 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2022-02-03 09:32:00 |
OncoSil approved for Innovation Funding (NUB) in Germany |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8fcc30582986302a8c7863527c0a7e79 |
|
2022-02-22 16:36:00 |
Half Yearly Report Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c4f239621b387027a69c3b7f7238b82c |
|
2022-02-22 16:36:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/83f2609a4d14e4e6ee6ec5a6b21fab5d |
Half Year Directors' Statement
Half Year Directors' Report
|
2022-03-28 09:48:00 |
Fully-Funded Trial Approved In Germany |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13de628d95742ee0a9a227e0c4dae3ed |
|
2022-04-13 09:18:00 |
First Commerical Pancreas Treatment In Spain |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c6b24d6d58bfdece226bf7a4acb9c596 |
|
2022-04-27 09:15:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/67ff5d6c593114ab0b110e7c75ee3bc7 |
|
2022-04-29 09:12:00 |
OncoSil Signs Commercial Agreement With Hospital In Spain |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dadbcdd20e4d81ca91d060cd37b4978c |
|
2022-04-29 09:18:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1366c70d40eb161f4b61b8ff45ebfe88 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2022-04-29 09:52:00 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/50c3417cf9944dcbea9da84ada3eb241 |
|
2022-04-29 09:52:00 |
OncoSil Launches $10m Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d34155869cca6de60ce4cc22456eadc |
|
2022-04-29 09:54:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a15f59f22e62abf80e6ab2728155697 |
|
2022-04-29 09:54:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d9f5b96522a44a5010b96c797f52519 |
|
2022-05-02 09:23:00 |
Clarification Of Non-Renouncable Entitlement Offer Details |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea06bcd1ca88e6d09a92d42fb1cb4680 |
|
2022-05-09 16:06:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd3675ab5bcfad0b5de5eb9e2f86f1be |
|
2022-05-09 16:08:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8dd629d5f00df9e7fa8e170f8517bfb1 |
Appendix 2A (Application for Quotation of Securities
|
2022-05-10 16:07:00 |
Letter To Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61ffe879919dacebfa8130d661ed9426 |
|
2022-05-10 16:07:00 |
OncoSil Entitlement Offer Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/51efe390c0ba22ff4cfca304930f2825 |
|
2022-06-08 09:06:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8f2d9031d47cf241c760c07690e4480 |
|
2022-06-09 09:46:00 |
Entitlement Offer Results and Shortfall Notification |
1 |
https://app.sharelinktechnologies.com/announcement/asx/917770d77cded968384f47018b56e4ab |
|
2022-06-10 09:55:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c48143527437e50293937e390f119611 |
Appendix 2A (Application for Quotation of Securities
|
2022-06-14 16:19:00 |
Change of Director's Interest Notice - Martin Cross |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c8e12f43d607946933fa0f3b6f5058b |
Change of Director's Interest Notice
|
2022-06-14 16:20:00 |
Change of Director's Interest Notice - Nigel Lange |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d5951e4f67c582003cc209b9f1bdeca |
Change of Director's Interest Notice
|
2022-06-14 16:21:00 |
Change of Director's Interest Notice - Otto Buttula |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d184f5a06b4878945459386d5b4eac62 |
Change of Director's Interest Notice
|
2022-06-14 17:01:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c69202b4ba3798678d9a28726e0323d |
|
2022-06-14 17:04:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c04ffabdccc272c61b0a7fd2b023dc24 |
Appendix 2A (Application for Quotation of Securities
|
2022-06-29 09:03:00 |
OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e0ae787697213c83d9e8890923e6878b |
Company Administration - Other
|
2022-06-30 08:25:00 |
FY 2023 Strategic Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/74d040207a8c8977ac1a9c1bcc5560c8 |
Company Administration - Other
|
2022-07-04 08:46:00 |
Bupa UK Approves Reimbursement for OncoSil in the UK |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c99e0ccca8df27fe7a7d7f375c651d4 |
Company Administration - Other
|
2022-07-19 08:50:00 |
Patient treated in Spain proceeds to successful resection |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d7fbaaaa00e5497dcf6dd328db3b320c |
|
2022-07-29 09:57:00 |
Monthly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c32470f3f487cf91c7e9d00a81464f9 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2022-08-01 16:48:00 |
Investor Presentation Webinar Wednesday 3rd August 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fb727069eac80ec792122d57af003439 |
Notification of Results/Reporting Date
|
2022-08-03 13:57:00 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ca6fe7ada8085ebc7802409f7c126fa5 |
|
2022-08-31 08:37:00 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/155306cbdc4873c0bc380e7fe7676269 |
Full Year Directors' Statement
Full Year Directors' Report
|
2022-08-31 08:38:00 |
Appendix 4E Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b7c6699b23bf5bb088dbdcf9064f970 |
|
2022-08-31 09:31:00 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3db5da8bd324fccbb668ad49bb8e87c6 |
|
2022-09-15 09:06:00 |
Brian Leedman appointed to the Board of OncoSil |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d537f8c59e14abc45d660fb8d9edc219 |
Director Appointment/Resignation
|
2022-09-16 08:25:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/886bd1faf0ffacd0ad7f1698c49e5cb3 |
Initial Director's Interest Notice
|
2022-09-23 16:07:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c8376bc6f41c03d5a420bb22f29d693 |
Notice of Annual General Meeting
|
2022-09-23 17:13:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a40c27c0d9f1844855c83ec0761fb07c |
|
2022-10-18 09:24:00 |
OncoSil to Present at South-West Connect ASX Showcase |
1 |
https://app.sharelinktechnologies.com/announcement/asx/372bed469daac56ea707ead24fbc56bd |
|
2022-10-24 08:19:00 |
OncoSil Receives $832k R&D Tax Incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56ac9e33e3bec29e9017b2807eaa7427 |
Company Administration - Other
|
2022-10-24 16:10:00 |
Resignation of Director - Dr Martin Cross |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09e49d0378c272462ee5ed93a85ba2d2 |
Notice of Annual General Meeting
Director Appointment/Resignation
|
2022-10-24 16:12:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7c223431e2988612ec1b10a98e6ccd0 |
Final Director's Interest Notice
|
2022-10-25 11:25:00 |
2022 AGM CEO Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c177722aa7d2b93c1de57a51c4f378df |
|
2022-10-25 16:03:00 |
Results of the OncoSil 2022 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f558744ed05a6f90a96ab0f45cee6875 |
|
2022-10-25 17:11:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ea6e0a8509706e6a79f4f2bd451690e |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-10-25 17:23:00 |
Change of Director's Interest Notice - Otto Buttula |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a43952b2980827bab26d33ab8a29325f |
Change of Director's Interest Notice
|
2022-10-25 17:25:00 |
Change of Director's Interest Notice - Ricky Sharma |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d0b2ef55775246cd8c4034bb2501a7d |
Change of Director's Interest Notice
|
2022-10-25 17:32:00 |
Change of Director's Interest Notice - Brian Leedman |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2aa0ed0351c06be82a20c3d8214b85d5 |
Change of Director's Interest Notice
|
2022-10-25 17:46:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3a3c0db688ebca605e0ea1ccff2ec514 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-10-25 17:58:00 |
Change of Director's Interest Notice - Nigel Lange |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f8f8f9925a4b42f722a7c0591935c87 |
Change of Director's Interest Notice
|
2022-10-27 08:17:00 |
OncoSil to present at AusBioInvest 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99ba01130f195a01c1e0691d7cb1caf8 |
Company Administration - Other
|
2022-10-31 16:07:00 |
Change of Registry Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a01e374363e5cc65ca3af1b3a1f5536b |
Details of Share Registry address
|
2022-10-31 16:43:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4f6a52882d53b6be264dabbfe23d21de |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2022-11-07 08:30:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/74590a4649bb4631b8ebbc257a4d60ea |
Change of Director's Interest Notice
|
2022-11-07 08:31:00 |
OncoSil to present at TechKnow Invest 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0251e3cf811f7d5c7f41be64a7611a94 |
Company Administration - Other
|
2022-11-24 09:29:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1250a20c67f1608ca6195edd3212f7d |
|
2022-11-24 09:30:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/933abe1a8fe970fa362bfcb17aa54780 |
Appendix 2A (Application for Quotation of Securities
|
2022-11-24 09:38:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3af303c6b9cc3ac2a3fee6632be11eb |
Change of Director's Interest Notice
|
2022-12-14 09:04:00 |
Distribution agreement signed for selected Chinese markets |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa5f104317e2057dce13c3c3ca45fbbe |
|
2022-12-15 08:17:00 |
OncoSil achieves milestone of 10 patients treated in Spain |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a732f5ef9ca98cf002a636bafb30a60b |
|
2023-01-31 08:40:00 |
Two key treatment centres treat first patients with OncoSil |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5d9cd10bbb499be158c701a5591f690d |
|
2023-01-31 11:37:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b71ed5a249a06898c5e0fc9e8ecfcc24 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2023-02-28 16:19:00 |
Half-Yearly Report Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78f3d87c1aca03c65372a18c3e355a93 |
|
2023-02-28 16:19:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd2949b0b0f92152ee26a1f820b04de2 |
Half Year Directors' Statement
Half Year Directors' Report
|
2023-03-06 17:38:00 |
Cancellation of Unlisted Options and Loan Funded Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f6fb5f30849e759ae158bee8ab28c0b2 |
Alteration to issued capital
|
2023-03-06 17:39:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da58fed18f380789cb8534b387405642 |
Change of Director's Interest Notice
|
2023-03-06 17:41:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6efd6dea3bde8b471582808fbca2722d |
Final Director's Interest Notice
|
2023-03-17 09:40:00 |
Entitlement Offer to raise up to $9.9 million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f31d32053b347827b6e5e3214fb3a8ee |
|
2023-03-17 09:42:00 |
Entitlement Offer Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d4401abf8993e4f883b139c9f54150f2 |
|
2023-03-17 09:43:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25239074422a8c7c6561238c86ad435f |
|
2023-03-17 11:35:00 |
Commitment received for Offer and updated Timetable |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea7b9847000958ccdb8fb3d0b389bc6c |
|
2023-03-17 11:38:00 |
Update - Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a326e6a0ab9b466681064156707a7b70 |
|
2023-03-20 08:42:00 |
Non-renounceable Rights Issue Offer Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7db5470e4ad2df52a255f8c53ce04ff7 |
|
2023-03-28 17:32:00 |
Entitlement Offer - Despatch of Documents |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c624f37a37432c5f7048deb20b46584 |
Company Administration - Other
|
2023-03-28 17:33:00 |
Letter to Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a00ff0ef11c16e2f0acc2ca589d46db |
|
2023-04-21 10:02:00 |
Additional Binding Commitment Received for Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/65a3dcec73dc05d77da1970cbb23c1d3 |
|
2023-04-21 16:02:00 |
Extension of Closing Date of Entitlement Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf2e7cae6860d5f2cc5afad722d3ca2d |
|
2023-04-24 09:15:00 |
Further commercial milestones achieved in Spain |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1887f81ad8d851a8df1f1421d1ddd9d6 |
|
2023-04-24 09:16:00 |
Oral presentation at The Mayo Clinic IMPACT Course |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f5b981ad847d74f36740f694206301f2 |
|
2023-04-24 11:53:00 |
Update - Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3008592e9be538f2dd2437a9df51ec92 |
|
2023-04-24 19:13:00 |
Late Lodgement of Change in Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c85020607b54c8ea4d725a39a1ad16f |
Change of Director's Interest Notice
|
2023-04-28 16:06:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/48aabf036d22a65676f5c5205fd56e08 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2023-05-01 09:25:00 |
First year anniversary of the OSPREY post-marketing registry |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57c5bf1c636ec42cd44cfe765121af30 |
|
2023-05-02 08:48:00 |
OncoSil to streamline operating structure |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0203ae4626b2d862c344b334f78892d3 |
|
2023-05-03 08:47:00 |
First patient enrolled in the TRIPP-FFX Clinical Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/77a7d44b556e55f502c6bf0da193fb5a |
|
2023-05-09 16:53:00 |
Entitlement Offer Results and Shortfall Notification |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e45f6fae50e0c6c745b7286713f80332 |
|
2023-05-11 10:32:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27d169a553dd1fcb0ab148bd9a12172d |
Appendix 2A (Application for Quotation of Securities
|
2023-05-11 11:21:00 |
Top 20 Holdings and Distribution Schedule of OSLO Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85c27c00aa8c73b5a2ed24211dfe6713 |
Company Administration - Other
|
2023-05-11 16:20:00 |
Change of Director's Interest Notice - Nigel Lange |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7fb74ff1faef52ba4c79616c1fcf946 |
Change of Director's Interest Notice
|
2023-05-11 16:22:00 |
Change of Director's Interest Notice - Brian Leedman |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a2cd2236b08cf0ecd43724da378f8eb |
Change of Director's Interest Notice
|
2023-05-12 08:32:00 |
Notification of cessation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5aa5ddcecb8ba77981f0f020c527c35c |
Appendix 3H (Notification of cessation of securities)
|
2023-05-12 09:02:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00e54a644cbbfa99c93a18fae708b8ad |
Becoming a substantial holder
|
2023-05-22 09:11:00 |
First patient treatment in Italy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/caa2b40553484bf0257a340520cc1549 |
|
2023-05-24 09:03:00 |
Mr Otto Buttula to Retire from the Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0c094a5cb6e1c2304903465ddd3bf91 |
Chairman Appointment/Resignation
|
2023-05-24 09:14:00 |
Resignation of Chief Financial Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c31d67c64d1aebb7743ca0831ddd4f0d |
Company Secretary Appointment/Resignation
Company Administration - Other
|
2023-06-01 09:09:00 |
Change of CFO, Company Secretary and Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4315092c8a3be1960d55a4523d5c8e01 |
Details of Registered office address
Company Secretary Appointment/Resignation
Company Administration - Other
|
2023-06-05 09:31:00 |
Ethics Committee Approves PANCOSIL Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78f44bd60cb99fb3fd475caf4debec22 |
|
2023-06-29 17:51:00 |
Notification of cessation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38677148cf577464650c1629ad29cacc |
Appendix 3H (Notification of cessation of securities)
|
2023-06-30 09:49:00 |
Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7ecd0c4ca3d87a4ca87ba8bde0cb4f60 |
|
2023-07-04 10:15:00 |
Change of Directors Interest Notice - Appendix 3Y OB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de99c3524b1e06f015d375f4c0918e89 |
Change of Director's Interest Notice
|
2023-07-14 16:33:00 |
Gabriel Liberatore appointed to the Board of OncoSil |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dad73f9af99d0445bb9b86a9e590a035 |
Director Appointment/Resignation
|
2023-07-18 12:24:00 |
Initial Director's Interest Notice GL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56c504c0130c05a09b1d7926b5ca4830 |
Initial Director's Interest Notice
|
2023-07-28 09:50:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00ecbc2f2b75bb828afa8f010a666a58 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2023-08-07 08:38:00 |
Douglas Cubbin appointed as Incoming Chairman of OncoSil |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73e37c308305081dfdf9d44bf0394ac8 |
Chairman Appointment/Resignation
|
2023-08-10 08:59:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92d6909df58078deb263a9e53cc53f18 |
Initial Director's Interest Notice
|
2023-08-16 17:43:00 |
Change of principal place of business |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e87d8fc8176c879997d7912d31c5c1b2 |
Details of Registered office address
|
2023-08-31 16:56:00 |
Appendix 4E and Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/16fe24124b01df41b21650af969d7832 |
Full Year Directors' Statement
Full Year Directors' Report
|
2023-08-31 16:59:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f612908f1189c37ad0275223e27c53c |
|
2023-08-31 17:00:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdfd93db750af276caf158d9e38d15a8 |
|
2023-08-31 17:30:00 |
Otto Buttula retires and Douglas Cubbin appointed Chair |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d15bcf3fd780f0bca6175a5dd17c719 |
Chairman Appointment/Resignation
|
2023-08-31 17:32:00 |
Final Director's Interest Notice OB |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34891035ff1bdce3a7a7fe7958bf66ba |
Final Director's Interest Notice
|
2023-09-13 08:36:00 |
Notification of cessation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bba7dade1830ff21eabae7908fb8426c |
Appendix 3H (Notification of cessation of securities)
|
2023-09-18 16:56:00 |
Mr Brian Leedman to retire from the Board of OncoSil |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae6d7811a64ff9ddd53c1b9c5fca2334 |
Director Appointment/Resignation
|
2023-10-04 15:30:00 |
Date of AGM and Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7e744afb618b27248d44f4fc1019451 |
Notice of Meeting - Other
Company Administration - Other
|
2023-10-30 14:49:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40a3b256057f3540887e24347d62d8b3 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2023-10-31 08:13:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7aeef51f248c6636fde839503be51057 |
Notice of Annual General Meeting
|
2023-11-24 12:54:00 |
OncoSil gaining traction in the Israeli healthcare market |
0 |
https://app.sharelinktechnologies.com/announcement/asx/403a0948e0d52cc1756bf060e7ca4252 |
|
2023-11-29 08:43:00 |
OncoSil onboards first patient in PANCOSIL Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0905d804cee0b799b94bdfaf28c5e4d4 |
|
2023-11-29 09:25:00 |
Presentation to Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/905cf9d7b1c6791d0a9d0d72f2c4e013 |
Chairman's Address to Shareholders
|
2023-11-29 13:06:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c6e29bb76da9fc7ad483bfdd0d40730 |
|
2023-12-05 16:32:00 |
Final Director's Interest Notice BL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4715ca56094b19c14b0c1bb7e64ad957 |
Final Director's Interest Notice
|
2023-12-06 10:50:00 |
Notification of cessation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6032ee34914c8bfc20e96cf0b95c7843 |
Appendix 3H (Notification of cessation of securities)
|
2023-12-08 08:19:00 |
First two commercial patient treatments in Greece |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5e00fd7a89e48cb783136cbc7cef5e01 |
|
2023-12-15 09:59:00 |
OncoSil receives $1.1m R&D tax incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/04733f5c9cb1acd49bf9036134b177a6 |
Company Administration - Other
|
2023-12-18 16:46:00 |
Notification of cessation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8133c525482fa703a503eef29f1d0e1b |
Appendix 3H (Notification of cessation of securities)
|
2023-12-18 17:18:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b56d956b8d04ed0dc8c17330c060a87c |
|
2023-12-19 16:39:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf5fbcfce9186f4cdafd3ca789e3dd66 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-12-19 17:02:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bfe3b0da283875737c8e98eeb4763bf8 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-12-20 15:26:00 |
Change of Director's Interest Notice DC NL GL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50d396fa2b79f4ad0cb610851803912f |
Change of Director's Interest Notice
|
2024-01-31 11:30:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/756087e64f892aaecf6e723e42284378 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2024-02-01 10:10:00 |
84 German hospitals can negotiate fee for Oncosil device |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8b526024a4229c177edbd697e8002664 |
|
2024-02-01 10:11:00 |
OncoSil signs distribution agreement for Turkish market |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed2202f0ae92cf6b68c64cd4ad04ab48 |
|
2024-02-28 17:22:00 |
Appendix 4D and Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/674b6426e52eefa1d9d2b451be30f484 |
Half Year Directors' Statement
Half Year Directors' Report
|
2024-03-18 09:46:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1dad513b9e7c4db6dd80e2ef2457132d |
|
2024-03-20 10:20:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a89f5c0fdd49f4bda276d3c4c1048da7 |
|
2024-03-20 10:20:00 |
Placement and Entitlement Offer to raise up to $7.1 million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/777935f5bb999b605a51c023ad1ad807 |
|
2024-03-20 10:20:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/db6aeec6010c73c65deaee82f4d87c28 |
|
2024-03-20 10:20:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71cd2f8cdf50a134947e8b8681fdce74 |
|
2024-03-20 10:28:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc5b07ccd34f8c30987242166290b7d0 |
|
2024-03-21 09:32:00 |
Placement and Entitlement Offer - addendum |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d70f1738ab3fe5d1dec4d9118e2ac398 |
|
2024-03-22 08:20:00 |
Update - Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56a46654d6d1ca2081f5fa8bcfbff27c |
|
2024-03-22 14:32:00 |
Placement and Entitlement Offer - amended timetable |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1b8d15b3042b3a529465bf828f2fcd7 |
|
2024-03-22 14:50:00 |
Update - Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3a739149cecfd0409f6a7803491697d |
|
2024-03-25 08:54:00 |
Prospectus - Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5ad2dcc7e51fc8ef5c0270a900b5fa42 |
|
2024-03-28 16:02:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d200eded6e0499b9b2bb532ff5a1aac |
Appendix 2A (Application for Quotation of Securities
|
2024-03-28 16:12:00 |
Notice under section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13e0779ca29c24b24ba753877569c181 |
|
2024-04-04 09:35:00 |
Dispatch of Entitlement Offer Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/44660f68b473fd214553a0c3e39acc60 |
Company Administration - Other
|
2024-04-05 08:38:00 |
First Austria-based treatments utilising the OncoSil device |
1 |
https://app.sharelinktechnologies.com/announcement/asx/42809e08dc9ec022816baa505e7280d2 |
|
2024-04-09 09:34:00 |
UK Private Insurer Approves Reimbursement for OncoSil |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9983325ebf7a1909d4984231ed9a1ccf |
|
2024-04-12 08:26:00 |
First patient treated in the UK for the TRIPP-FXX study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8aeb71cfe62fdd441096e65ca2186c18 |
|
2024-04-16 08:47:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33f76c28a60fae2e24f9994ea82798d5 |
Notice of Extraordinary General Meeting
|
2024-04-16 08:58:00 |
First patient treated with OncoSil device in Turkiye |
1 |
https://app.sharelinktechnologies.com/announcement/asx/689219eed903e896a7036ea04aabf555 |
|
2024-04-17 17:07:00 |
Two more PANCOSIL Trial treatments using OncoSil device |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ffa35276cc35b2d384cb317bf2f453be |
|
2024-04-30 15:52:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c17a2da9a62e8f8960e976b3d58c51c0 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2024-05-01 08:28:00 |
1st Study in Man Increases Pancreatic Tumor Vascularity |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee563a8f3b7d77fbbb1f2f1f1457b5c7 |
|
2024-05-02 10:48:00 |
$5.3 million raised under Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/68eb0cb637cb7b4ba97c786b7b8c1fa7 |
|
2024-05-02 10:52:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d053f1fa9ffbebed03451b5618cea19d |
Appendix 2A (Application for Quotation of Securities
|
2024-05-02 10:57:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9755687a6e081512494a9d6bfe1c6a38 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-03 17:10:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34e0f045fca1470f5698cfac502907f3 |
Appendix 2A (Application for Quotation of Securities
|
2024-05-03 17:11:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdc61a9feba86dbfe7732be1a1c8ecce |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-08 16:34:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30d2f386b4a68f640e6a94a66207d0f0 |
Appendix 2A (Application for Quotation of Securities
|
2024-05-08 16:39:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1823cd031ec1808e4a6579bfa487e65e |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-10 17:05:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d52c5c7b3c85c5ed062be19af092311 |
Appendix 2A (Application for Quotation of Securities
|
2024-05-10 17:14:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e4c1a460179b9971e8fa04cd0833461 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-15 12:51:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8336287b4417baf9fb97e12c5aa6a245 |
|
2024-05-15 16:24:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46969ae89b40665a0abc3e1f51b77992 |
Appendix 2A (Application for Quotation of Securities
|
2024-05-15 16:26:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d3e639bb0aa930783366e4ca9dabc81 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-20 15:14:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/940e0c7c3349798180e304a1c2300c6c |
Appendix 2A (Application for Quotation of Securities
|
2024-05-20 15:17:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83da586e869c7a65896f410c092a6120 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-05-20 15:33:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43086878c879b4652036cb8c8422ae16 |
Change in substantial holding
|
2024-05-23 08:44:00 |
OncoSil signs distribution agreement for Saudi Arabia |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e47a86f0dd9d30aa44c8439ade1f59a |
|
2024-06-03 08:59:00 |
200th patient treated with the OncoSil device |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cf48b8095446c3f23b52f34f27f461ea |
|
2024-06-11 08:59:00 |
5th patient is treated in PANCOSIL trial |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2902110ec65ee9c94de5dfb9962ade7f |
|
2024-06-21 16:11:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/361d7ca98d7300347bc40715f36537bc |
|
2024-06-24 16:23:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f7358ba4903d855a34ddc20232e0198 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-07-03 18:00:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/124fa6cf5e01bea277a3f09b4e237669 |
Appendix 2A (Application for Quotation of Securities
|
2024-07-03 18:04:00 |
Notification regarding unquoted securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30d1a379617674b9acf1d197cc174fee |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-07-10 12:36:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de6aba0534767fa65dcd400a38b21ac5 |
Appendix 2A (Application for Quotation of Securities
|
2024-07-10 12:37:00 |
OSL Short Dated Options Range of Units and Top 20 Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5ba9d03042680692a52f571d3d3d82d |
|
2024-07-12 09:14:00 |
Letter to Short Dated Option Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25a51ba6973b730ec3cda414dbd40822 |
Letter to Shareholders - Other
|
2024-07-15 09:09:00 |
Director Appointment/Resignation PH |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17f99362f51c2b9d333761344b929882 |
Director Appointment/Resignation
|
2024-07-15 11:02:00 |
Peter Hall to be appointed Non-Executive Director (addendum) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f24a06dd2227b169c3a4198a66f300c |
Director Appointment/Resignation
|
2024-07-23 15:36:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f4ed6024b35b677f25f5fe624788bd9a |
|
2024-07-25 09:19:00 |
Australian institution to invest $2.7 million in OSL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/75ffb2892a0b2b773685946957bfc190 |
|
2024-07-25 09:25:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a9a36ebed4f2433efb48d4ee05b192e |
|
2024-07-25 09:28:00 |
Proposed issue of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6f07df56652ad5b1e5b5d568f4a6878 |
|
2024-07-29 08:40:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/677f8a3b58a2323e4255b2d814e3d08e |
Appendix 2A (Application for Quotation of Securities
|
2024-07-29 08:43:00 |
Notice under section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4505cbd699346cbbca154b43e0dda46c |
|
2024-07-30 14:56:00 |
Becoming a substantial holder from PCG |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57a001bba7b98bb875fdeece3aefd69b |
Becoming a substantial holder
|
2024-07-31 10:18:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98070888712479d415b66c5b9bcc3e20 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2024-07-31 17:14:00 |
Notice of Initial Substantial Holding from SOL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf811ccd506f0bc840f99d3f9193b411 |
Becoming a substantial holder
|
2024-08-07 09:08:00 |
Application for quotation of securities - OSL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5b2f90b3fb1a011ea5af5fc696b390ee |
Appendix 2A (Application for Quotation of Securities
|
2024-08-07 09:27:00 |
Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e96e625f080e9315d6f8109e99c6ba7 |
|
2024-08-14 17:02:00 |
Ceasing to be a substantial holder SC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d411b8c0bb7b9848ca9773860f7d4b2 |
Ceasing to be a substantial holder
|
2024-08-15 10:05:00 |
Successful Treatment with OncoSil Device in Turkiye |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0259699b8507c46103fc6ba014215dba |
|
2024-08-15 10:13:00 |
Significant Growth in Commercial Treatment Sales in Q4 FY24 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1698a0bab0c9acd566b62c45056b7332 |
|
2024-08-20 08:25:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6392558d8b5e307ba22b71563fb43b93 |
Notice of Extraordinary General Meeting
|
2024-08-30 08:59:00 |
Appendix 4E Preliminary Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fe48f781b215218d9ffff7ba5344f77d |
|
2024-08-30 15:00:00 |
Appointment of Peter Hall as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5318bc58aa510ae4451be28509c9dd56 |
Director Appointment/Resignation
|